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Abstract
Campylobacteriosis is caused by the gram-negative bacteria Campylobacter and
is a leading cause of gastrointestinal illness worldwide. In the United States an estimated
2.4 million cases occur annually with approximately $8.0 billion in associated costs. Due
to the high cost of morbidity, understanding the epidemiology and risk factors of
campylobacteriosis is important. It is unclear if the prevalence of campylobacteriosis is
higher or lower in East Tennessee than other parts of the state or country or if the clinical
characteristics of patients in the area are similar to the rest of the country. Therefore, the
purpose of the study was to describe clinical and epidemiological characteristics of
campylobacteriosis patients in East Tennessee to assist in health planning to control
campylobacteriosis. Data from the Foodborne Disease Active Surveillance Network was
analyzed for 2003-2006 in 16 counties in East Tennessee. The data was first assessed for
its quality, then descriptive statistics were calculated and spatial and temporal patterns of
reported cases and risk factors were assessed. The overall error rate in the data quality
analysis was 6.5% although in the last year of the study it was only 2.6%. The mean
annual prevalence of campylobacteriosis in East Tennessee was 10.4 cases per 100,000
population, which was 1.6 times higher than all of Tennessee (7.4 cases/100,000).
Grainger and Jefferson Counties had higher age- and sex-adjusted prevalence estimates
than the region and nation. It is yet unclear why this region has a higher prevalence of
campylobacteriosis than the rest of the nation. The highest age-specific prevalence (41.6
cases/100,000) was observed in children under 5. Disease prevalence was consistently
higher in the summer months compared to the other seasons. The median age of patients
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was lower in the most rural counties. More patients in East Tennessee were hospitalized
than the rest of the nation. The most commonly reported risk factors were animal and
raw meat exposure. Improvement in data collection and entry is necessary to improve the
quality and application of this surveillance data. Educational efforts on proper hygiene
following animal handling, and proper well protection and disinfection should be targeted
at high risk groups.
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Preface
Unless otherwise specified, Campylobacter and Campylobacter spp. refer to C.
jejuni and C. coli, the most common species identified in human disease. Tables and
figures follow the page on which they are first referenced.
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1.0 Introduction
Campylobacteriosis is caused by the gram-negative bacteria Campylobacter.
Members of the Campylobacter species are small, non-spore forming, gram-negative
bacteria that have a characteristic curved, S-shape or spiral morphology[1]. They were
first observed and described in 1886 but were first cultured in 1977[2]. Campylobacter
jejuni and Campylobacter coli exhibit a similar clinical course of enteric disease and are
therefore often grouped together in descriptions of disease characteristics. An estimated
2.4 million people suffer from campylobacteriosis each year in the United States; 13,000
of these patients require hospitalization and 124 die[3]. The average patient misses 3.8
days of work or school due to campylobacteriosis[4], but chronic sequelae can increase
this number. It is estimated that campylobacteriosis costs $8 billion a year in the United
States[5], from lost wages and medical expenses related to the primary infection and any
secondary complications.
Of all human Campylobacter infections, it is estimated that 85 to 99% are caused
by C. jejuni and 5 to 10% by C. coli with C. fetus making up the remainder[6, 7].
Infection caused by C. jejuni or C. coli results in acute enteritis with clinical courses that
are hard to differentiate from those of other bacterial pathogens that cause acute
gastrointestinal infections such as Salmonella or Escherichia coli. Common symptoms
are diarrhea (which may be bloody), nausea, fever, headache, myalgia and vomiting[8].
Most cases are self-limiting but complications can occur. These include reactive arthritis,
or Guillain-Barré syndrome (observed in 1 out of 1000 campylobacteriosis patients)[9].
Campylobacter fetus rarely causes enteritis although it has been isolated in systemic
1

blood infections. It induces fever and can disseminate to numerous tissues such as the
vascular endothelium, bones, and joints. Complications of C. fetus infection may include
meningitis, endocarditis, pneumonia, thrombophlebitis, septicemia, arthritis, and
peritonitis[10].
Commonly identified risk factors for human infection with C. jejuni and C. coli
are chicken consumption or handling, international travel and animal exposure[11-14].
In all exposure cases, the bacteria must be ingested in some form. Campylobacter spp.
are zoonotic and also infect household pets such as dogs and cats as well as livestock
such as poultry and cattle and wild animals as well. Many animals remain asymptomatic
while infected but are still able to shed the bacteria in their feces. Due to this, poor
hygiene following any animal contact may result in infection. Water can become
contaminated by fecal run off which is also an important source of infection[15].
Campylobacter is the most common bacterial cause of diarrhea in the United
States[3] and many other developed countries[16, 17]. The overall reported incidence
varies worldwide, depending on the reporting practices, healthcare systems, risk factor
distributions and hygiene levels in each country. The reported incidence of
campylobacteriosis ranges from 300-396 per 100,000 in New Zealand[18, 19] to 12.7 per
100,000 in the United States[20]. These incidence figures only include the patients who
sought medical care for their illness and on whom laboratory tests were conducted. Due
to this under-reporting, the true incidence of campylobacteriosis is most likely higher
than the figures reported in the United States and other countries worldwide.
The state of Tennessee belongs to the Foodborne Active Surveillance Network
(FoodNet) which conducts active surveillance for all foodborne pathogens, including
2

Campylobacter. Under the active surveillance, every positive laboratory report for
Campylobacter must be reported to the health department. Additionally the health
departments also conduct routine reviews of all the diagnostic laboratories in their
jurisdiction to ensure all cases that are detected are reported in a timely fashion. After a
case is identified, a health department representative contacts the patient to collect
additional data.
The incidence of campylobacteriosis in Tennessee is 7.4 per 100,000[20], but
public health officials in East Tennessee (16 counties in the eastern portion of the state)
have noticed that the incidence in this region appears to be higher[21] than the rest of the
state of Tennessee. It is unclear if the incidence in East Tennessee is truly higher than the
rest of the state, or if there is a reason for the increased prevalence in the region. It is also
unclear if the clinical characteristics of the patients in this region are similar to the rest of
the country. This study is designed to determine the characteristics and risk factors
among the cases of campylobacteriosis reported in East Tennessee. Understanding the
disease characteristics specific to the region can help to improve disease control and
prevention strategies. Demographic characteristics of reported cases will be assessed to
identify high risk groups. The most commonly reported risk factors and clinical
symptoms reported by the patients will be identified. Geographical and temporal patterns
and any association between geographic location, risk factors, clinical symptoms and
socioeconomic determinants of health will be investigated. By understanding the most
common risk factors in the study area, the regional and local health departments will be
able to better implement health programs to reduce future disease occurrence.
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2.0 Literature Review

2.1

Etiology
The genus Campylobacter is a member of the division Proteobacteria, class

Epsilobacteria, order Campylobacterales, family Campylobacteraceae[22]. This family
is made up of gram-negative bacteria that are primarily commensals or parasites of
humans, domestic animals[23], and wild mammals.
Members of the Campylobacter species are small, non-spore forming, gramnegative bacteria that have a characteristic curved, S-shape or spiral morphology[1]
They are 0.2 to 0.9 µm wide and 0.5 to 5.0µm long with one or more spirals. Cells have a
single polar unsheathed flagellum, at one or both ends, that is used for motility[24].
Some species, such as C. gracilis are non-motile. The flagella may be up to 2-3 times the
length of the cells[22]. Campylobacters were first observed and described in 1886 by
Theodor Escherich as non-culturable spiral-shaped bacteria that were isolated from the
intestinal contents of 16 of 17 children who died of diarrheal disease[25]. Escherich
observed what he described as a “vibrionen” numerous times in the feces of human
neonates and kittens with diarrhea[26]. While it is not certain that what Escherich
described were indeed Campylobacters, their morphology, failure to grow on solid
media, and association with enteric illness all seem to suggest that they were indeed
Campylobacters. In 1906, McFadyean and Stockman isolated an unknown spiral bacteria
from sheep experiencing epizootic abortions [27]. Due to their curved, Vibrio-like
appearance (similar to members of the genus Vibrio), the bacteria were given the name
4

Vibrio fetus in 1919 by Theobold Smith who was investigating infectious abortions in
cattle[28]. Another species of Vibrio was identified in 1931 by F.S. Jones who was
investigating infectious diarrhea in cattle, he named it Vibrio jejuni [29]. In 1963, Sebald
and Véron noted that V. fetus and V. jejuni differed from the classical cholera Vibrios.
They discovered that V. fetus and V. jejuni have a lower guanine plus cytosine (G plus C)
DNA content compared to other Vibrios, and are unable to ferment carbohydrates[30].
Due to these differences, a new genus Campylobacter (meaning “a curved rod”) was
created.
Campylobacter species are considered microaerophillic because they grow best in
atmosphere that contains only 3-15% oxygen, although some will grow under aerobic or
anaerobic conditions, when necessary[22]. For energy, Campylobacters use amino acids
or tricarboxylic acid cycle intermediates, such as α-ketoglutarate, succinate or fumarate.
However all strains are not able to metabolize the same carbon sources[31]. All
Campylobacter species will grow at 35 - 37°C but thermophillic species (C. jejuni C.
coli, C. lari and C. upsaliensis) grow best at 42°C[24]. Table 2.1 shows all species of
Campylobacter and their phenotypic characteristics[32].
Species that are important in human infections are C. jejuni, C. coli, C. fetus, and
to a lesser degree C. lari and C. upsaliensis. The primary species identified in
gastrointestinal illness are C. jejuni and C. coli; they are responsible for an estimated 9099% and 5-10%, respectively, of human Campylobacter infections.
C. fetus can be broken down into two subspecies, C. fetus subsp. fetus and C. fetus
subsp. venerealis. C. fetus subsp. fetus primarily causes abortion in sheep and
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Table 2.1: Phenotypic characteristics differentiating Campylobacter species
Species

Catalase

Nitrate
reduction

Nitrite
reduction

H2S
production
(TSI)*

Hippurate
hydrolysis

Indoxyl
acetate
hydrolysis

Growth at :
25 °C 42 °C

Growth
in 1%
glycine

Alkaline
phosphatase

Susceptibility to:

‡

NA†

C

GC
content
(mol %)

Campylobacter coli

+

+

-

-

-

+

-

+

+

v

S

R

30+33

Campylobacter concisus

-

+

+

+

+

-

-

+

+

v

R

R

37+41

Campylobacter curvus

-

+

+

+

-

+

-

+

+

ND

S

ND

45+46

Campylobacter fetus subsp.
fetus
Campylobacter fetus subsp.
venerealis
Campylobacter gracilis

+

+

-

-

-

-

+

-

+

-

R

S

33+35

+

+

-

-

-

-

+

-

-

-

R

S

33+34

-

+

+

ND

ND

ND

ND

ND

ND

ND

R

ND

44+46

Campylobacter helveticus

-

+

ND

-

-

+

-

+

+

-

S

S

34

Campylobacter hyoilei (C. coli)

+

+

+

+

-

ND

ND

v

+

ND

S

R

35

Campylobacter hyointestinalis
subsp. hyointestinalis
Campylobacter jejuni subsp.
doylei
Campylobacter jejuni subsp.
jejuni
Campylobacter lanienae

+

+

-

+

-

-

v

+

+

v

R

S

33+36

+

-

-

-

v

+

-

-

+

+

S

S

30+31

+

+

-

-

+

+

-

+

+

+

S

R

30+33

+

+

+

-

-

-

-

+

-

+

R

R

36

Campylobacter lari

+

+

-

-

-

-

-

+

+

-

R

R

30+32

Campylobacter mucosalis

-

+

+

+

-

-

-

+

+

v

R

S

36+38

Campylobacter rectus

-

+

+

+

-

+

-

w

+

ND

S

ND

45+46

Campylobacter showae

+

+

+

+

-

+

-

+

v

-

R

S

44+46

Campylobacter sputorum bv.
bubulus

-

+

+

+

-

-

-

+

+

-

R

S

29+30

Campylobacter sputorum bv.
fecalis

+

+

+

+

-

-

-

+

+

v

R

S

30+32

Campylobacter sputorum bv.
sputorum

-

+

+

+

-

-

-

+

+

ND

S

S

30+31

w/-

+

-

-

-

+

-

+

v

v

S

S

32+36

Campylobacter upsaliensis

‡

TSI: Triple Sugar Iron test, NA: nalidixic acid; C: cephalothin, GC: Guanine-Cytosine content
Test results: +, positive reaction; -, negative reaction; w, weak reaction; v, variable reaction; R, resistant; S, sensitive; ND, not determined
Table adopted from: Logan, J.M., et al., Campylobacter lanienae sp. nov., a new species isolated from workers in an abattoir. Int J Syst Evol Microbiol, 2000. 50 Pt 2: p. 865-72.
*

†
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sporadically in cattle, but has also been isolated from human aborted fetuses in rare
occasions. In humans, C. fetus subsp. fetus causes systemic infection and occasionally
gastrointestinal infections[22]. C. fetus subsp. venerealis can cause abortion and
infertility in cattle. Unlike C. fetus subsp. fetus, C. fetus subsp. venerealis is unable to
multiply in the intestinal tract of humans and other animals[33].
C. upsaliensis has frequently been isolated from canine and feline fecal specimens
of both healthy and diarrheic animals[34-37]. It is classified as thermotolerant since only
80% of isolates tested have been shown to grow at 42°C[38, 39], unlike the thermophillic
species where all strains can grow at 42°C. C. upsaliensis has been isolated from human
fecal samples but infection with this species appears to cause less vomiting and
nausea[39]. Unlike other Campylobacter species that cause enteric infections, C.
upsaliensis has been associated with hemolytic uremic syndrome, a serious complication
affecting the kidneys[40]. Since C. upsaliensis is sensitive to the antibiotics used in
selective media for the routine culture of C. jejuni and C. coli, other techniques must be
used to isolate this species. C. upsaliensis can be isolated by filter techniques, but these
methods are not routine in most diagnostics laboratories and are usually not requested by
the physician ordering the stool culture. Due to the decreased ability to isolate the
bacteria, the burden of human disease from C. upsaliensis has been difficult to estimate
and is currently unknown[41].
C. lari has been isolated from the intestines of shore birds in Sweden[42], water
samples in New Zealand[43], shellfish in the Netherlands [44], and pigs in Texas[45]. It
has been also been identified as a cause of bacteremia in humans[46, 47] but the true
burden of disease is unknown. C. lari was originally described with the phenotypic
7

characteristic of nalidixic acid resistance, but several strains have been isolated that are
nalidixic acid susceptible. This is important since the phenotypic response to nalidixic
acid is often used to differentiate between species and this could lead to misidentification
of species. The nalidixic acid resistance is also important because nalidixic acid is the
basis for the quinolone class antibiotics and fluoroquinolones are often the antibiotic of
choice for treating Campylobacter infections[48, 49]. Although the current burden of
disease from lari is low, more campylobacteriosis treatment failures could occur if the
burden of disease due to C. lari increases and the empiric treatment of
campylobacteriosis with fluoroquinolones is continued.

2.2

Campylobacter Survival in the Environment
In order to survive long enough to be passed from one host to another,

Campylobacters must endure stress factors such as exposure to oxygen, lower
temperatures and desiccation. As such they have developed mechanisms to survive in
different environments until the bacteria can find a new host to colonize.
One survival mechanism involves the ability to enter a viable but nonculturable
(VBNC) state[50]. Campylobacter cells transform from a motile spiral form to a coccoid
form when they are subjected to unfavorable conditions such as low nutrient availability
or incubation at temperatures outside the optimum growth temperature[51]. During this
state, Campylobacter does not undergo DNA replication or protein synthesis[52-54], but
it is believed that proteins are synthesized when the cells initiate the VBNC state[55].
While experimental results are not always comparable (most likely due to strain
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variations) VBNC Campylobacter cells have been resuscitated in animals in the
laboratory[56-59], from aquatic environments[60], and after treatment with acid[61].
Cells can be resuscitated up to 30 days after entering the VBNC state[60].
The formation of biofilms is another technique by which Campylobacter spp. can
survive in extreme conditions. A biofilm is composed of microcolonies of organisms,
including bacteria, fungi, and protozoa, bound together by an extracellular matrix that
provides a microenvironment separate from outside low nutrient and hostile
conditions[62]. Biofilms are widely distributed in the environment and occur in most
public water supplies and plumbing systems[63]. C. jejuni has been isolated from
biofilms in aquatic environments and on stainless steel[63, 64]. Depending on the
incubation temperature and microbial make up of the biofilm, C. jejuni has been
documented to survive for 42 days in that environment[63]. Lower temperatures (4°C
instead of 22°C) have been shown to lengthen the time that Campylobacter spp. can
survive in aqueous environments[63].
Campylobacter spp. has been isolated from surface water sources in the USA[65],
UK[66, 67] and New Zealand[68]. The presence of Campylobacter in these water
sources may be due to fecal run off.

Studies have shown that C. jejuni is capable of

surviving in manure spread on grass for up to 63 days depending on the type of manure
and animal source[69]. The longest Campylobacter survival time was recorded for dairy
cattle slurry or liquid waste and beef cattle solid waste. Pig slurry and sheep solid waste
had the shortest survival times at only 16 days, while Campylobacter survived in poultry
solid waste was 42 days. Another study found that when the solid manure is stored in
heaps the survival time is decreased to 2-4 days due to the heat in the center of the
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heap[70]. The same study also showed that Campylobacter survived about half as long
when spread on sandy soil compared to clay soil.
It has been estimated that up to 80% of retail chickens for sale in the United States
are contaminated with Campylobacter spp.[71]. The meat most likely becomes
contaminated after evisceration in the poultry processing plant due to cross
contamination. C. jejuni have been reported to have better survival rates on poultry meat
with the skin intact compared with skinless meat[72]. Under normal refrigeration
conditions, all meat types contained enough bacteria for an infectious dose for
humans[72].
It has also been shown that Campylobacter spp. can be isolated from kitchen
surfaces even after cleaning with detergent and hot water[73]. Authors of one study were
able to isolate viable bacterial cells from beech and polypropylene cutting boards up to 2
hours after inoculation[74]. The ability of C. jejuni to survive even a few hours on
kitchen surfaces provides ample time for cross contamination to other foods. It has also
been shown that C. jejuni is able to survive for 24 hours on strawberries stored at room
temperature and for 72 hours on cantaloupe stored at 7°C[75].

2.3

Clinical Course
Infection with Campylobacter spp. can result in several clinical manifestations.

Human volunteer studies have shown that asymptomatic infections occur[76]. The most
common clinical manifestation is enteric, resulting in acute diarrheal disease. Enteric
infections can sometimes lead to systemic infections if the bacteria invade the intestinal
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cells and cross into the bloodstream. Systemic infection is characterized by fever and
joint pain[10]. Post infection complications of enteric illness include Guillain-Barré
syndrome (GBS) and reactive arthritis[9].

2.3.1 Enteric Infections
Campylobacter infection causes acute diarrheal disease with clinical symptoms
that are similar to those of other bacterial pathogens that cause acute gastrointestinal
infections. The most common presentation is acute enteritis. Symptoms caused by C.
jejuni and C. coli usually start with abrupt cramping pain in the abdomen that is quickly
followed by diarrhea. Approximately 30% of the patients experience a prodrome of fever,
headache, myalgia, dizziness, anorexia or malaise prior to the onset of diarrhea[1, 11,
77]. The prodromal symptoms appear 12-24 hours prior to intestinal symptoms and this
has been shown to indicate a more severe clinical course compared to patients who
experience diarrhea first [78]. Diarrhea can vary from loose stools to stools that are
profuse and watery, bloody, bile stained or slimy. In descriptive reports of outbreaks, the
most frequently reported symptoms are diarrhea and abdominal pain. In Denmark, 95%
of patients reported diarrhea and 86% reported abdominal pain[79]. Similarly, in two
different outbreaks in Spain (2001 and 2003), diarrhea was reported by 100% and 93.6%
of afflicted patients and abdominal pain was reported by 62.5% and 89.6% of patients,
respectively [80, 81]. In surveys of emergency room patients, it was shown that more
than 50% had 10 or more bowel movements a day[78]. Nausea is commonly reported but
vomiting is reported less often than nausea[78, 82]. The duration of symptoms may last
for 1-7 days or longer depending on the virulence of the species and or strain and the
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immunological status of the patient[83]. On average, patients remain ill for 1-4 days but
a study in Denmark found the median duration of all illness to be 10 days[11].
Using data from 17 point source outbreaks, the average incubation period was
estimated to be 3.2 days, with a range of 18 hours to 8 days [8]. The authors of that study
reported that the upper and lower bounds of the range may have actually been sporadic
cases that were not actually part of the true outbreaks investigated. Outbreak data is
usually used when calculating the incubation period since it is normally difficult to
pinpoint the source of infection in sporadic cases. The Centers for Disease Control
reports the average incubation period to be 2-5 days with a range of 2-10 days [84]. This
slightly longer incubation period can be useful in separating Campylobacter from other
gastrointestinal bacterial pathogens. Other common pathogens that cause diarrhea,
abdominal cramps and fever are nontyphoidal Salmonella, enterotoxigenic E. coli, and
Shigella; these bacteria have average incubations periods of 6-48 hours, 6-48 hours and
2-4 days, respectively.
A re-occurrence of symptoms is reported by 15-25% of patients whose recurring
symptoms are severe enough to cause them to revisit their physician[8]. The rate of
relapse may be higher since not all cases will revisit their physician for the same illness if
their symptoms are mild. The clinical course of the relapse is normally characterized by
abdominal pain and may vary from a relatively mild gastroenteritis to an enterocolitis
with bloody diarrhea, lasting for several weeks[85].
Patients will continue to shed Campylobacters in the feces for several weeks after
recovery. Some studies have shown that convalescent shedding period may be reduced if
the antibiotics are administered early in the clinical disease course[86]. A meta analysis
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of 11 double-blind studies of antibiotic use for the treatment of Campylobacter enteritis
showed that the duration of intestinal symptoms was only shortened by 1.3 days with
antibiotic use[86]. The same study showed that the duration of diarrhea was twice as
long if the patient waited more than 3 days to seek medical treatment. Another study
found that the average patient will wait 4 or more days before seeking medical care[87].
This delay in seeking medical care prolongs disease duration and may limit the
usefulness of antibiotic treatment.

2.3.2 Systemic Infections
Campylobacters are invasive bacteria that are able to translocate and reach the
blood stream; however bacteremia in human Campylobacter enteritis patients is rarely
reported. A study in England found an average bacteremia rate of 1.5 cases of
bacteremia per 1,000 intestinal infections, with a high degree of variability associated
with age[88]. Elderly patients (over 65 years of age) had the highest rate of 5.9 per 1,000
intestinal infections while young children ages 1-4 had the lowest rate at 0.3 per 1000
intestinal infections[88]. Campylobacter fetus rarely causes enteritis and it has been
isolated more frequently in systemic blood infections. It induces fever and can
disseminate to numerous tissues such as the vascular endothelium, bones, and joints.
Complications from C. fetus infections can include meningitis, endocarditis, pneumonia,
thrombophlebitis, septicemia, arthritis, and peritonitis[10].

2.3.3 Post-Infection Complications
Although most cases of campylobacteriosis are self-limiting, complications such
as reactive arthritis or Guillain-Barré syndrome (GBS) have been documented following
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infection. However, reactive arthritis can follow infection by other intestinal bacteria
such as Salmonella. The frequency of documented joint pain following Campylobacter
infection ranges from <1%[77] to19.9%[11]. This percentage depends on the prevalence
of the Human Leukocyte Antigen B*27 (HLA B27) tissue antigen in the population
surveyed; it can range from 0-50%[89]. HLA B27 is a surface antigen on the B locus of
the major histocompatibility complex and presents antigens to T cells; it has been
strongly associated with certain autoimmune diseases. Patients with the antigen have a
strong predisposition to reactive arthritis. In most cases the joint pain lasts a few weeks
to months and almost all result in a complete recovery[8]. Other local complications
such as appendicitis, peritonitis, cholecystitis, hepatitis or pancreatitis may occur but are
rare.
Guillain-Barré syndrome is an autoimmune-mediated disorder of the peripheral
nervous system. Affected patients will rapidly develop progressive weakness in their
limbs and respiratory muscles and a loss of reflexes. While the disease is generally selflimiting, up to 20% of patients require mechanical ventilation for a portion of their
recovery[90, 91] and 15-20% are left with severe neurological deficits[92-94].
Campylobacter enteritis is reported as the most frequent antecedent event for GBS
accounting for 30-40% of all GBS cases[95, 96]. Of patients who develop GBS after
campylobacteriosis, the GBS symptoms normally develop 1-3 weeks after recovery from
their gastrointestinal symptoms. Some studies have suggested that patients who develop
GBS after Campylobacter infection may have a more severe course of GBS than those
who develop GBS from other causes[97]. One study found that on average, 1 out of
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every 1000 patients with C. jejuni infection will develop GBS, but in patients with the
O19 strain, the rate increases to 1 out of every 158 [9].

2.4

Immune Response/Immunity
The self-limiting nature of the clinical disease course in most campylobacteriosis

patients indicates that in individuals with a healthy immune system there is an effective
immune response defense mechanism to clear the infection. Further evidence of this is
supported by studies involving HIV-infected patients who have a defective cellular
immune response. Immuno-defficient patients experience more severe symptoms, a
higher frequency of relapses and may suffer from bacteremia from C. jejuni because their
immune system is unable to clear the bacteria when it reaches the bloodstream[98].
Black et al[76] studied experimentally infected humans, and reported that
infection may provide some protection against future infections. Seventy-two adult
volunteers ingested various doses of C. jejuni strain A3249; 75% became infected and
18% were symptomatic. One month later two volunteers, who were previously infected
and experienced symptoms, were re-challenged along with five new volunteers. Neither
of the re-challenged volunteers became infected while all five new volunteers did
(P=0.048). Another group of 39 adult volunteers were given varying doses of C. jejuni
strain 81-176; 100% of these volunteers became infected (all had positive stool cultures)
and 46% were symptomatic. Seven members of the 81-176 strain group were rechallenged a month later along with twelve new volunteers. None of the re-challenged
volunteers developed diarrheal illness while 6 of the 12 new volunteers did (P=0.034). In
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both experiments patients were re-challenged with the same strain of C. jejuni showing
that infection can provide short-term homologous immunity.
The exact mechanisms of the host recognition of the bacteria and immune
response are unclear. Both an innate and adaptive immune response are involved in the
response to invasion and colonization by C. jejuni and C. coli[99]. The innate immune
response is also called non-specific or broad-specific immune response since the cells
that are part of the response do not recognize a specific invading pathogen; rather they
recognize all foreign cells and acts as soon as the foreign cells are recognized. The innate
immune response also initiates the adaptive immune response which has cells that are
designed to recognize a specific foreign cell but requires a lag time for antibodies to be
produced.

2.4.1 Innate Immune Response
Recent studies have indicated that structural components of the bacteria and
proteins synthesized by C. jejuni during invasion and adhesion elicit an innate immune
response from the intestinal epithelial cells[100]. A study at the Naval Medical Research
Center in Maryland suggested that C. jejuni can induce the release of interleukin-8 (IL-8)
by two mechanisms. One requires adhesion to the epithelial cell wall and/or invasion
into the cell and the other is activated by surface proteins on the cytolethal distending
toxin (CDT)[101]. IL-8 is an inflammatory chemokine that attracts neutrophils to the site
of the infection, where the responding neutrophils are able to phagocytose the invading
bacteria and clear it from the cell. Another study at the University of Nottingham in the
United Kingdom found that C. jejuni was a transcriptional activator of NF-κB (nuclear
factor-kappa B)[102]. NF-κB functions as part of the innate immune response by
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stimulating the transcription of the genes for cytokines and chemokines[103]. The
resulting secretion of cytokines/chemokines and other mediators leads to the activation of
macrophages and the recruitment of polymorphonuclear leukocytes in the inflammatory
response. Macrophages ingest and phagocytose invading cells. Macrophages also play a
role in the adaptive immune response by acting as antigen presenting cells in the creation
of antibodies. In in-vitro experiments, when human T84 epithelial colon cells were
cultured with C. jejuni, the epithelial cells up regulated the expression of dendritic cell
and T-cell chemoattractants[104]. These chemoattractants bring T-cells to the site of the
infection. The T-cell and mature dendritic cells then act as antigen presenting cells and
activate the adaptive immune response[105, 106].

2.4.2 Adaptive Immune Response
The adaptive immune system produces an antibody response that is specific to
Campylobacter infections. Antibody production is a delayed response. The initial
specific antibodies, immunoglobulin M (IgM) are produced by the 8th day post infection,
and IgG first appear around 10 days after the first symptoms, while IgA peaks about 2
weeks post onset of symptoms[107]. Although IgM is short lived and IgA disappears
after 5 weeks, IgG has been detected in the sera of infected individuals up to a year post
infection[108]. A study of workers in a poultry processing facility found that long-term
workers (working for > 1 month) had significantly higher anti-Campylobacter IgG
concentrations than the short-term workers. There was no significant difference detected
in the levels of IgA[109]. This indicates that the long-term workers have been exposed in
the past, and have circulating IgG from past exposures that the short-term workers have
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not developed yet. Current exposure is the same for both long- and short-term workers so
no IgA differences are observed.
Studies of populations in hyper-exposed regions of the developing world have
shown that in young children, an increase in age correlates with a decrease in the illness
to infection ratio[110]. In these populations children develop a resistance to colonization
between 2-5 years old. The convalescent excretion period is shortened with age due to a
gradual increase in Campylobacter-specific circulating antibodies as the child ages[111].
A study of children in Bangladesh found that levels of IgA continued to increase
throughout childhood, while IgG peaked between 2-4 years old and IgM reached a
plateau at the same age[112].
Further evidence of the immunity provided by IgA was studied in a population of
infants in Mexico. The attack rate for diarrhea caused by C. jejuni was significantly
higher (p <0.0005) in the group of infants that were not breast fed compared with the
infants that were breast fed. The human breast milk of the infants who were fed breast
milk fed infants and who developed diarrhea did not contain anti-Campylobacter specific
IgA[113]. Babies that are breast fed receive milk that has the same antibodies as their
mother. Thus in the group of infants who were breast fed but still developed diarrhea, the
mother did not have the antibody to pass on to her baby.
A study of IgA in adults was carried out amongst United States military personnel
participating in military exercises in Thailand. Personnel who had a pre-travel anti-C.
jeuni antigen IgA titer less than 450 were 1.6 times as likely (P=0.05) to have
campylobacteriosis associated diarrhea during their stay in Thailand than the personnel
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who had a pre-travel titer greater than 450[114]. This indicates that high levels of IgA
may provide short-term immunity against future infection.

2.5

Diagnosis
The original isolation of Campylobacters from stool was achieved in 1968

through the use of membrane filtration and culture. Campylobacters are able to pass
through a filter membrane, due to their smaller size, while other bacteria that may be
present in the stool sample cannot not[115]. In 1977 Martin Skirrow developed a
selective media, for the culture of Campylobacter, containing vancomycin, polymyxin B,
and trimethoprim in a blood agar base with lysed horse blood[2]. Since the development
of Skirrow’s culture media, several variants have been developed depending on the type
of sample (fecal, environmental or water) in order to obtain more growth quicker,
eliminate other competing bacteria and make the media cheaper to prepare[116-119].
Culture remains the gold standard for clinical diagnosis, although the media used may
differ from laboratory to laboratory. Some laboratories have started to again use
membrane filtration and a less selective media in order to culture C. upsaliensis[120],
which cannot grow on the standard culture media.
The antimicrobial agents in the standard selective culture media (Skirrow’s or
similar media) are inhibitory to C. upsaliensis and some strains of C. jejuni and C. coli.
Since their growth is normally inhibited in most diagnostic laboratories, the incidence of
C. upsaliensis, which also causes enteric infection, is underreported. Another drawback
of the standard culture method is the long incubation time (48 hours) required to grow an
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isolate. Once Campylobacter colonies have formed on the culture plate, phenotypic tests
are required to confirm the isolate and determine the species. These tests include the
morphology, motility, catalase, oxidase, hippuricate hydrolysis test, indoxyl acetate
hydrolysis, production of hydrogen sulfide (H2S) and the antibiotic sensitivity to
cephalothin and nalidixic acid. One problem with the phenotypic tests that are designed
to differentiate between the species is that not all strains within a species behave the same
for each test; 5-8% of C. jejuni isolates do not express hippuricase activity which has
been considered a hallmark of C. jejuni colonies[11].
Dark-field microscopy as a method of rapid diagnosis of campylobacteriosis was
proposed in Colorado in 1982[121]. Dark-field microscopy involves examination of the
stool sample for the presence of organisms with the typical darting or corkscrew motion
of Campylobacter spp., and the presence of leukocytes or erythrocytes. While this test
can be performed quickly, its sensitivity is only 36% and this falls to 28% if the stool
samples are viewed more than two hours post collection[121]. This decline in sensitivity
could be due to a lack of motility, due to death of the organism. While the specificity
was 99%, the overall positive predictive value (probability, given a positive test that a
patient has the disease tested for) of this method of diagnosis was only 62%.
Due to the above indicated drawbacks with the culture method for diagnosis of
Campylobacter enteritis there has been considerable work to look for a new diagnostic
method. A Latex agglutination test has been developed to help confirm and identify the
species in place of the phenotypic tests, but an evaluation of the test found it lacked the
ability to differentiate between C. jejuni/C. coli and C. upsaliensis or C. lari[122]. The
analysis of this test found that the sensitivity was 100% for C. jejuni or C. coli isolates,
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but only 87% if all isolates tested are included and only 14% of Campylobacter isolates
other than C. jejuni and C. coli. The specificity was reported at 100% of the 101 nonCampylobacter organisms that were tested[122].
An enzyme-linked immunosorbent assay (ProSpecT Microplate assay; AlexonTrend, USA) is on the market for the rapid detection of C. jejuni and C. coli from fecal
samples. This test has been evaluated on multiple occasions and the sensitivity has been
reported at 96, 89.1 and 80%, while the specificity was reported at 99, 97.7 and
100%[123-125]. Tests using PCR to detect Campylobacters directly from human fecal
samples have been developed, but due to the materials and labor required, are currently
only used in the research setting[77].

2.6

Treatment
The majority of symptomatic Campylobacter infections are acute and self-

limiting, as such most patients do not need antimicrobial therapy and only require oral
replacement of fluids and electrolytes[82]. However, severely ill patients may need to be
admitted to a hospital for parenteral fluid replacement and antimicrobial treatment in
addition to oral re-hydration therapy. The antibiotics normally recommended to treat
human campylobacteriosis are fluoroquinolones (ciprofloxacin and levofloxacin are the
most common) and macrolides (erythromycin, azithromycin and clarithromycin). Some
fluoroquinolones (enrofloxacin and sarofloxacin) have been used in the past for the
prophylactic treatment of poultry.
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Antibiotics may be warranted in patients that have a bloody stool, high fever,
prolonged illness (defined as symptoms lasting longer than 1 week), pregnancy, and
when there is coinfection with HIV or AIDS or other immunosuppressant conditions. In
these situations erythromycin and azithromycin are the current drugs of choice[126-129].
While there is a small amount of resistance developing to erythromycin, it remains the
drug of choice recommended by the CDC. Antibiotic therapy should only be used when
necessary in order to limit further emergence of resistance to potentially life saving drugs.
Since resistance rates vary by country and class of antibiotic, clinicians should consider
where the infection originated when choosing antibiotic therapy[130, 131].
Erythromycin is the more cost effective macrolide when compared to
azithromycin (the newer macrolide), yet both are equally as effective. C. coli has shown
high levels of resistance to erythromycin. However, the incidence of infection by C. coli
remains low in the United States so macrolides are still recommended for treatment of
campylobacteriosis. Ciprofloxacin[132] and Norfloxacin[133] have been shown to be
successful in reducing the duration of symptoms but an increasing prevalence of
fluoroquinolone resistance has emerged so continued use of fluoroquinolones to treat
campylobacteriosis is cautioned.
The empiric treatment of enteric infections is controversial due to the emergence
of antibiotic resistance, and the possibility of treatment failure and relapse or future
resistance to all antibiotics. Children who are treated empirically with antibiotics before
the etiologic agent is determined, may be at a higher risk of hemolytic uremic syndrome
if the agent of infection was E. coli O157:H7 (a more frequent cause of bloody
diarrhea[134]), not Campylobacter spp.[135]. Clinicians, in some cases, will not
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establish the etiologic agent responsible for an enteric infection before starting antibiotic
treatment; therefore it is important to consider the possibility of antibiotic resistance and
related complications when selecting antibiotic therapy. One study found that the
usefulness of antibiotic therapy decreased dramatically if it was not administered early in
the infection[86]. Although, the majority of campylobacteriosis infections are relatively
mild and therefore do not require antimicrobial therapy, severe cases require antibiotic
treatment, early in the clinical course, if possible. In such cases it may be important to
perform antibiotic susceptibility test to ensure appropriate choice of medications.

2.7

Antibiotic Resistance

2.7.1 Prevalence
In recent years the resistance to fluoroquinolones has rapidly increased
worldwide[136], and resistance to macrolides is on the rise in some areas[137].
Worldwide the prevalence of antibiotic resistance varies depending on the species of
Campylobacter concerned and the class of antibiotic in question. In Ireland, dramatic
increases were observed in the prevalence of resistance between 1996/1998 and 2000.
They tested a collection of C. jejuni and C. coli and found that while resistance to
erythromycin had remained constant at 2%, resistance to tetracycline increased from 14%
to 31%, and resistance to ciprofloxacin had increased from 0% to 30%[138]. In separate
susceptibility tests of C. coli isolates in Germany and Spain, 29.4%[139] and
34.5%[140], respectively, were resistant to erythromycin. None of the German isolates
and only 3.2% of the Spanish C. jejuni isolates were resistant to erythromycin. The
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observed prevalence estimates of resistance to ciprofloxacin was 45.1% in Germany[141]
and 72% in Spain[140], greater than the percentages of resistance in Ireland.
In developing countries antibiotics are often sold unrestricted which can lead to
improper usage in humans and animals[142]. In Thailand Campylobacter spp. resistance
to ciprofloxacin was 84% in 1994. In a study of mixed isolates from children in Lagos,
Nigeria, 79.8% were resistant to erythromycin[143].
In the United States, the prevalence of resistant strains is not as high as other parts
of the world, but it is on the rise. In Minnesota, the prevalence of resistance to
ciprofloxacin was only 1.3% in 1992 and but had increased to 10.2% by 1998[144]. Due
to this increasing trend of antibiotic resistance, the National Antimicrobial Resistance
Monitoring System for enteric bacteria (NARMS) was established in 1996. NARMS was
established as a collaborative effort between the Food and Drug Administration's Center
for Veterinary Medicine (FDA CVM), U.S. Department of Agriculture (USDA), and the
Centers for Disease Control and Prevention (CDC)[145]. The goals of NARMS are to
provide data on the extent and trends of antimicrobial drug susceptibility and resistance
for enteric bacterial organisms and to inform physicians and veterinarians of the patterns
they observe. A total of 297 isolates were tested in 1990 by the Centers for Disease
Control (CDC), prior to the creation of NARMS, and no ciprofloxacin resistance was
detected. However, the percentage of resistance had increased to 13% of 217 isolates
tested by NARMS in 1997 and 19% of 384 isolates in 2001[146]. Resistance to
erythromycin is variable between C. jejuni and C. coli at 1-5% and 5-9% of isolates,
respectively[137].
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2.7.2 Complications of Antibiotic Resistance
Several studies have shown that patients with a quinolone resistant strain of C.
jejuni experience a longer duration of illness than those with a quinolone sensitive
strain[147]. In Minnesota, patients who were treated with fluoroquinolones and were
infected with a fluoroquinolone resistant strain had a median duration of diarrhea of 10
days while those who were infected with a fluoroquinolone sensitive strain had a median
duration of diarrhea of only 7 days (p=0.03)[144]. FoodNet data collected in 1998-1999
showed that patients who took no antidiarrheal medication and were infected with
ciprofloxacin resistant strain had a mean duration of diarrhea of 9 days while those who
were infected with a ciprofloxacin sensitive strain only experienced 7 days of diarrhea
(p=0.04)[148]. The same was shown by a study in Denmark in 2001-2002 where patients
with a fluoroquinolone resistant strain had a mean duration of illness of 13.2 compared
with 10.3 days of the sensitive strain patients(p=0.001)[147].

2.7.3 Controversy with Antibiotic Usage in the Poultry Industry
The rise of fluoroquinolone resistance appears to coincide with the widespread
use of related fluoroquinolones in large scale food animal production, especially poultry
production. This is important since raw and undercooked chicken is considered a major
risk factor for C. jejuni infection. Two fluoroquinolones, sarafloxacin and enrofloxacin,
were licensed for use in US poultry in 1995 and 1996 respectively, and by 1997 13% of
217 human isolates submitted to NARMS were resistant to fluoroquinolones when no
fluoroquinolone resistance had been detected in prior years[146]. Due to this apparent
link Abbott Laboratories withdrew sarafloxacin from use in poultry in 2000 and the FDA
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withdrew enrofloxacin from the market for poultry in 2005 (after Bayer Corporation
disputed the link for 4 years[149]). In the United Kingdom, a survey of retail chickens
prior to the licensure of enrofloxacin for use in poultry production in the UK, found only
3% of Campylobacter isolates from domestically raised chickens were resistant to
ciprofloxacin[150]. This study also tested chickens imported from mainland Europe,
including some chickens from France where enrofloxacin was licensed for use at the time
of the study. Of the imported chickens, 27% of the Campylobacter isolates were
resistant to ciprofloxacin. More evidence supporting the theory that the increase in
Campylobacter strains resistant to fluoroquinolones is linked with the use of
fluoroquinolones in poultry production is provided by a study conducted in Denmark.
Fluoroquinolones are not used in Danish poultry productions and the percentage of
human Campylobacter isolates that are fluoroquinolone resistant is only 6.5% for
infection acquired in Denmark compared to 67.4% of those infections acquired abroad
(including neighboring countries where antibiotics are used in poultry production). Due
to the high incidence of campylobacteriosis worldwide, it is important to limit the level of
antibiotics being used in poultry production due to the ability of bacteria to become
resistant through transfer from other commensal bacteria. If in the future, more strains
become resistant to more and/or different classes of antibiotics, the duration of illness
experienced by patients may be longer, and symptoms may be more severe.
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2.8

Pathogenesis
The pathogenic mechanism of C. jejuni has been debated and is still not

completely clear, one researcher called the mechanism “sketchy”[151].

Some of the

debate may be due the high degree of genetic and phenotypic diversity amongst C. jejuni
strains resulting in widely varying experimental results depending on the strain used.

In

general, Campylobacters enter the host intestine by passing through the stomach acid
barrier and colonize the distal ileum and colon. In order to colonize and cause disease, C.
jejuni uses a variety of mechanisms including bacterial cell motility and chemotaxis,
adhesion, invasion and cytotoxin as well as enterotoxin production[152].
Campylobacters are motile through the use of their uni-polar or bi-polar flagella.
The direction of their motion is driven by chemotaxis, which was first described in 1883
by Theodor Engelmann and in 1884 by Wilhelm Pfeffer[153-156]. Chemotaxis is
described as the movement of bacteria toward certain stimuli and away from others. C.
jejuni exhibits positive chemotactic behavior (movement towards) for L-fucose[157]
which is the terminal sugar in mucin, but it is repelled from bile components. Further
research has shown that amino acids L-aspartate, L-cysteine, L-glutamate, and L-serine,
and the organic acids pyruvate, succinate, fumarate, citrate, malate, and a-ketoglutarate
are all positive chemoattractants for C. jejuni[158]. All of the identified chemoattractants
are chemicals or compounds that are found in or near the mucosa of the epithelial lining
of the intestine, thus directing the bacteria towards its invasion target, the epithelial cells
of the colon and closer to the wall of the intestine to avoid being cleared by fluid flow.
Once a chemoattracting molecule is bound to a receptor on the bacteria,
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autophosphorylation of the Che proteins conveys the signal through signal
transduction[159, 160]. This same mechanism works to drive the bacteria away from
chemorepellents. The signal can be to change directions and or speed. C. jejuni has
shown the ability to move at higher velocities in more viscous environments due to its
shape and flagellar activity[161]. The flagella has been shown to be necessary to
overcome peristalsis and for entry into the mucous layer of the intestine[162] which
allows the bacteria to cause disease.
Adhesion of the bacteria to epithelial cells on the wall of the intestine has been
shown not to be essential for the colonization of the intestine, but it does facilitate cell
invasion[163]. C. jejuni can adhere to the epithelial cells by a variety of bindings; these
include polyoma enhancer binding factor 1, PEB1 (a homolog of Gram-negative ABC
transport systems)[164], Campylobacter adhesion to Fibronectin ,CadF (a fibronectin
binding protein)[165], a major outer membrane protein[166], lipooligosccharide[167] and
a novel surface-exposed lipoprotein specific to C. jejuni[168]. The ability to adhere to
the cell allows the bacteria to invade the intestinal lining.
Host cell invasion has been observed in experimentally infected infant macaque
monkeys[169] and swine primary intestinal cells[170], but no consensus has been
reached as to the mechanism or pathway[171]. The damage caused by toxins released
intracellularly and extracellularly can cause epithelial cell death. The cytotoxin,
cytolethal distending toxin (CDT), is a tripartite toxin of the AB toxin type; two parts,
CdtA and CdtC, form the binding components, while the third part, CdtB, is the active
subunit[151]. Once in the cell, CdtB is transported to the nucleus and arrests the cell in
the G2 phase of the cell cycle by causing double strand breaks in the DNA[172].
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Previous studies reported the cell cycle arrest was due to chromatin disruption[173]. This
cell arrest leads to apoptosis. Both the toxins and dead cells stimulate inflammation and
further epithelial damage leading to a loss of function of the intestinal mucosa. The toxin
alters the absorptive capacity of the epithelial cells, which causes water to rush out of the
cells resulting in watery diarrhea. Also as mucosal cells are damaged and die, they are no
longer able to carry out their normal absorption of fluid from the intestinal tract, resulting
in more fluid being passed in the stool and diarrhea[174]. In some cases, C. jejuni may
invade the sub-mucosa. When the cells from the sub-mucosa die and fall off, a pore is
opened that allows blood to enter the intestinal lumen resulting in bloody diarrhea.
Mucus may also be found in the stool due to loss of adhesion of the mucosal layer from
the damaged epithelium and due to the irritation of the mucin producing cells.
In response to the invasion, host cells release interleukin-8 (IL-8)[175] and
leukotrine B4 (LTB4)[176] which cause the recruitment of more polymorphonuclear
leukocytes and macrophages to the area. These inflammatory cytokines can cause fever
in the host by acting as pyrogens and increasing the set point of the hypothalamic
thermoregulatory center. The abdominal pain that is experienced by some patients may
be caused by the inflammatory response as well. The inflammatory response elicited by
the lipopolysaccharide interacts with signaling molecules that act on the enteric neurons
to cause abdominal pain or cramps[177]. The distention and irritation caused by the
inflammation of the small intestine and colon may cause vomiting as a result of the
stimulation of the visceral afferent neurons[178]. Excessive distention or irritation of the
duodenum provides the strongest stimulus for vomiting; impulses are transmitted by
vagal and sympathetic afferents to the bilateral vomiting center of the medulla[179]. The
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motor reactions are then initiated to cause vomiting. Nausea is the conscious recognition
of the subconscious excitation in area of the medulla closely associated the vomiting
center.
In most cases C. jejuni is sensitive to complement-mediated lysis and are killed
rapidly in the blood stream even in the absence of specific antibodies[180]. However,
there are some strains that are highly resistant to serum[181] and can colonize the blood
stream or survive for up to seven days in monocytes[182]. The ability to “hide” in
monocytes can result in long-term bacteremia in the host. This bacteremia can lead to
further complications such as meningitis or abortion if fetal infection occurs[183].
When specific serotypes (O:19 and O:41) of C. jejuni are present in the blood
stream, the lipooligosaccharide structures on the surface of the bacteria can molecularly
mimic peripheral nerve gangliosides[184]. This mimicry results in the generation of
autoreactive antibodies that cause nerve inflammation and tissue damage[185]. This
damage is the start of Guillain-Barré syndrome (GBS). One theory on GBS initiation is
that anti-self antibodies specific for the ganglioside to bind to the surface of Schwann
cells and this starts the disease progression[186]. That binding may activate complement
which forms transmembrane pores resulting in the tissue damage and loss of neural
activity[187].

2.9

Pathogenicity/Virulence
Campylobacter spp. must be able to colonize the intestine of the host in order to

cause disease. Therefore any mechanism that makes colonization easier may increase the
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pathogenicity of the organism. Pathogenicity and virulence of Campylobacter are
influenced by certain genes. For instance, research has evaluated how the loss of
function of certain genes affects the ability of C. jejuni to infect the host. The spiral
shape and flagellum of the individual bacteria enhance bacterial motility in viscous media
such as the surface layer of the intestinal mucus. Removal of the flagella function
through the creation of a mutation in the flaA gene resulted in decreased ability of C.
jejuni to colonize the gut of chickens[188]. Campylobacters use chemotaxis to help
control and direct motility. By creating a mutation in the chemotaxis regulator gene cheY
researchers were able to reduce the number of symptomatic ferrets compared with the
wild type[189]. That mutation made the bacteria unable to respond to signals from the
host environment. The CadF protein is an outer membrane protein that facilitates the
binding of C. jejuni to fibronectin. The disruption of the gene cadF results in the
inability of that strain to colonize the cecum of day old chicks[190]. Another protein that
plays a role in the adhesion of C. jejuni to the intestinal lining is PEB1 also known as cell
binding factor 1, CFB1. Disruption of peb1A gene caused significant loss in invasion and
adherence ability in cell culture and a significant decrease in the symptoms of mice
challenged with the mutant strain[191].
The cytolethal distending toxin (CDT) causes progressive cell distention and cell
death in cell culture experiments[192]. The genes cdt A, cdtB, and cdtC code for 3
proteins that combine to make a holotoxin that causes the cytolethal effect of arresting
cells in the G2 phase of their cell cycle[193]. These three genes have been found in
almost all strains of C. jejuni, and C. coli as well as strains of C. fetus and C.
upsaliensis[110], but the gene expression levels varies between strains of C. jejuni and
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between species. C. coli has lower expression levels which could explain why the
clinical course of enteritis due to C. coli appears to be milder[194]. Some strains have a
higher expression of the cdtABC genes, like the well characterized C. jejuni 81-176,
which appears to cause more severe disease. It has been hypothesized that the CDT has a
negative effect on the net absorptive ability of the intestinal epithelium through inducing
cell death and it affects the replication in active secretory immature enterocytes[110].

2.10 Epidemiology
2.10.1 Risk Factors
Most cases of campylobacteriosis are considered sporadic (they are not associated
with an identifiable outbreak of cases) as such determining the source of infection is
difficult. Therefore, there is substantial need to determine key risk factors for infection,
among sporadic cases, in order to help prevent future illnesses. Several risk factors have
been identified through case-control studies: poultry consumption, international travel,
drinking untreated water or unpasteurized milk, contact with animals or contact with
people who are similarly infected.
2.10.1.1

Consumption of Contaminated Food or Water

The most commonly identified risk factor is poultry consumption. Although each
case-control study varied slightly in the questions about the specific type of poultry or
where the poultry was consumed, 19 out of 24 case-control studies identified poultry
consumption as a risk factor for campylobacteriosis[11]. In a 1997 Danish study, they
separated poultry into 24 different categories, including popular brands and packaging

32

types, the only poultry exposure that was significantly associated with
campylobacteriosis was undercooked poultry (all-types)[13]. Undercooked chicken was
also found to be a significant risk factor for disease in the Denver and Fort Collins,
Colorado area in 1981[195], in the population older than 5 in Australia in 2002[196], in
the Eastern Townships of Québec in 2001[197], and in FoodNet sites in the United States
in 1999[198]. The FoodNet study reported the largest population attributable fraction
(24%) associated with the consumption of chicken in a restaurant. The association with
the consumption of chicken in restaurants, without differentiating if the meat was
undercooked, was also identified in New Zealand in 1995[199], and in Hawaii in
1998[200].
Other evidence supporting poultry as a risk factor for Campylobacter infection is
provided by a study in Belgium in 1999 when all poultry meat and eggs were removed
from the market due to contamination with dioxins. This resulted in a 40% reduction in
the observed number of cases based on the expected number of cases of
campylobacteriosis based on the predicted model from the previous years. The case
counts returned to the predicted values after poultry products were re-introduced to the
market[201]. A study in Norway found that eating poultry produced in Denmark or
Sweden was strongly associated with human infection while the consumption of poultry
produced in Norway was not[202]. The authors associated this with the low prevalence
of Campylobacter infection in the poultry flocks of Norway.
Drinking untreated water has been associated with outbreaks of
campylobacteriosis, and has been identified as a risk factor for infection in case-control
studies. A study in Colorado in 1981 found that cases were more likely than controls to
33

report having drunk “raw” (untreated) water from a stream, river or lake, OR=10.74[195].
Similar associations were found in England in 1991[203] and Sweden in 2002[204]. The
Swedish study also found that having a well as the household water source was
significantly associated with developing campylobacteriosis. Two studies in New
Zealand found non-urban household water sources [205] or rainwater as the water source
[199] to be associated with increased risk of disease. In Canada, an outbreak of
gastroenteritis caused by both Campylobacter spp. and E. coli O157:H7 was attributed to
cattle manure entering the municipal water supply following heavy rains[206]. A study
conducted in Finland in 2002 found that swimming in a natural body of water was a
significant risk factor for campylobacteriosis[207].
Other risk factors that have been identified are unpasteurized milk [13, 195, 197,
204, 208], anti-secretory drugs or consumption of milk from bottles that had lids that had
been attacked by birds[12], consumption of offal[196], sausages at a barbeque[202], red
meat at a barbeque [13], pork[13, 208], and grapes[13].
2.10.1.2

Animal Exposure

Animal exposure is another commonly reported risk factor. The species and age
of animal implicated varies from study to study. A study of infants in the United States
found that having any kind of pet with diarrhea in the household was associated with
increased risk of campylobacteriosis[14]. Another study of young children less than 6
years of age in Sweden in 2002 found that having a dog of any age in the household was
a significant risk factor (OR=8.4)[204] as did a Norwegian study in 1992
(OR=5.04)[202]. The US FoodNet study in 2004 found an association between all ages
of campylobacteriosis patients and puppies (OR=3.2)[198]. The Nottingham Health
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Region study of 1995 also implicated puppies as a source of infection[12]. Similar
associations with young dogs less than 6 months of age were found in an Australian study
of the population older than 5[196] and in one study of children less than 35 months of
age[209]. Cats or kittens were identified as risk factors in Colorado in 1981[195] and
Denmark in 1997[13]. Other animals that have been implicated as risk factors for
campylobacteriosis are chickens [13, 196, 208, 209], and cattle[199], [13].
Pets as a risk factor is supported by numerous cross sectional studies conducted
mainly in Europe that have shown that the prevalence of Campylobacter infections in
dogs ranges from 5% to 70%[34, 210-213] depending on the test used for diagnosis of
campylobacter and the living conditions of the dogs sampled. Dogs and cats show a high
prevalence of infection with C. upsaliensis[37], which can infect humans; however, it is
not regularly identified using standard diagnostic tests in the United States due to
inhibitory effects of the routine culture media[41]. When Campylobacter infection of pet
animals is limited to just C. jejuni, the prevalence ranges from 3% to 22%[37, 213, 214],
depending on the living conditions of the sampled animals. Although the prevalence of
C. jejuni in pet animals may be considered low, it is an important public health concern
since both healthy pets and those with diarrhea have been reported to have a similar
prevalence of infection[35] with equal possibilities of shedding bacteria in feces.
However, one study found a significant difference in the prevalence of infection between
healthy young (less than 1 year) dogs and diarrheic dogs of the same age[215]. These
results suggest that apparently healthy animals may just as likely to be infected with
campylobacter as sick animals, depending on the age of the animal, and these animals can
act as potential sources of infection to humans. Moreover, healthy carrier pet animals
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may shed the bacteria for up to several months which could be a source of recurrent
infection in a household.
Workers in the poultry industry are at a high occupational risk for Campylobacter
infections. One study of a factory in Northern Ireland found that poultry factory workers
were 3 times more likely to develop campylobacteriosis than the population of the
surrounding community (p = 0.016)[216]. At a poultry processing plant in Sweden, an
outbreak of campylobacteriosis occurred when the normal and experienced workers went
on holiday and were replaced with inexperienced teenagers[217]. Only 29% of the
experienced staff became sick during this outbreak, while 71% of the replacement
workers did, since the replacement works did not have immunity from previous exposure.
A case-control study in Michigan found that those who practiced poultry husbandry had
increased odds of campylobacteriosis compared to those who did not (OR = 6.884; 95%
CI = 1.438 - 32.954). The same study estimated that 18% (95% CI = 6% - 30%) of cases
of human campylobacteriosis that occur in rural populations are attributable to poultry
contact[218].
2.10.1.3

Other Risk Factors

Another risk factor that has consistently been identified in case-control and
descriptive studies of campylobacteriosis is international travel. In the FoodNet study in
1999, 13% of the cases interviewed reported international travel 7 days prior to the
development of symptoms, compared to only 1.5% of the controls, for an odds ratio
(OR=10.0)[198]. Travel abroad was also identified as a risk factor in Switzerland in
1991 with an OR of 21.2[219], in Denmark in 1997[13], and the Nottingham Health
Region in England in 1995[12]. Campylobacter spp. is frequently identified as the
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etiologic agent responsible for traveler’s diarrhea, adding to the implication of
international travel as a risk factor for campylobacteriosis[220, 221]. Other studies have
also identified antibiotic use[200], and diabetes[12] as risk factors for disease. It has
been hypothesized that antibiotics may provide a selective advantage to drug-resistant
bacteria by lowering the infectious dose required to produce disease, or that previous
antibiotic use may result in decreased colonic bacterial flora so there is less resistance to
colonization by Campylobacter spp[222, 223].
While person-to-person transmission is believed to occur, contact with someone
with similar symptoms has not been documented as a risk factor in Campylobacter casecontrol studies. Person-to-person transmission, however, has been documented among
family members [224] Childcare centers are prime locations for Campylobacter spp. to
be spread due to large numbers of children present and the decreased hygiene practices of
children in that age. In Brussels in 1991-1992 an outbreak of C. upsaliensis affected 44
children at 4 related child care centers[225]. Restriction fragment length polymorphism
(RFLP) showed that there were two clonal variants circulating, one variant affecting one
center and the other affecting the other three centers. In a case-control study of childhood
diarrhea of all causes in Sao Paulo, Brazil “not sending a child to a daycare center”
(childcare in the home) was found to be protective against diarrhea (OR= 0.58, P =
.004)[226].

2.10.2 Incidence
In descriptive studies of enteric illnesses in developed countries, infections by
Campylobacter spp. are among the most common. In Australia, Campylobacter
infections are the leading causes of gastrointestinal illnesses among all the notifiable
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enteric pathogens[17]. Campylobacter is the most common bacterial cause of diarrhea in
England and Wales[16] and in the United States, it is reported more frequently than any
other bacterial pathogen[3].
The incidence of disease varies widely worldwide, the highest reported incidence
occurs in the South Pacific. In New Zealand, the incidence of campylobacteriosis has
been reported at 300-396 per 100,000[18, 19] and in Australia the incidence was reported
at 116.5 per 100,000 in 2003[17]. The reported incidence risk (per 100,000) is slightly
lower in Europe at 95 in Switzerland[213], 82 in Denmark in 2001[227], and 66.65 in
2006 in Sweden[228]. The average incidence risk among sites participating in the
FoodNet program in the United States was 12.71 per 100,000 in 2006 and the reported
state incidence in Tennessee was 7.4 per 100,000[20]. While the reported incidence in
the US is lower than other parts of the developed world, it still represents an important
health issue, it has been estimated that the true incidence of campylobacteriosis in the US
is 800 per 100,000 population[3]. Differences in health care systems may influence the
reported incidence of campylobacteriosis. In countries where there is a higher
percentage of insured individuals, either by government universal healthcare or private
health insurance, these individuals will be more likely to visit the doctor when they are ill
compared to individuals who don’t have health insurance. In the United States it has
been reported that 16% of the populations does not have any form of health
insurance[229]. While countries like Canada have government health insurance plans
that are designed to ensure that all residents have access to health insurance. In these
countries, more cases will be reported since more individuals will visit their doctor and
are more likely to have their stool cultured. Due to under-reporting, the real incidence of
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campylobacteriosis may be closer to 900 cases per 100,000 people in the United States,
based on an estimate in 1999[3].
2.10.2.1

Demographic Distribution

All ages can be affected, but there appears to a bimodal age distribution. The
highest age-specific incidence occurs in young children[204, 230, 231]. Some reports
have categorized this incidence as all children under 5 years[4, 204, 231] while others
have been more specific, limiting the highest incidence to just children under 1 year[230].
In some studies, a smaller second peak has been documented, this occurs in young adults
of ages 15-30 years[4, 198, 232]. It has been hypothesized that the reason infants and
young children have the highest reported incidence, is that the parents of young children
are more likely to take their child to the doctor than themselves[233]. With more young
children seeking medical care there is a higher possibility of stool culture and
documentation by the reporting system[234]. Young children may also have a higher risk
of exposure due to decreased hygiene from some behavioral patterns, such as crawling on
the floor and putting objects in their mouths. Skirrow studied this in 1987, he calculated
the infection rate based on the total number of samples cultured; the lowest infection rate
was observed in infants under one year of age, and the highest infection rate was
observed in the 15-24 age group[235]. It has also been hypothesized that the reason
young adults (ages 15-30) have a higher reported incidence of campylobacteriosis is that
this is the age group that does the most international travel[4].
A study of the infectious disease surveillance system in Denmark, of >13000 stool
samples, found that female patients were more likely than males to be cultured for
Campylobacter infection (ratio of 1.2:1), although male patients were more likely to be
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culture positive (RR 1.27, 95% CI 1.21–1.34)[236]. The same study found that the
oldest age group (60 and older) were the most likely to have their stool cultured, while
the 15-29 age group was the most likely to be culture positive. A study in Norway found,
males were more likely to be infected overall, 57.5% of all campylobacteriosis patients
were male. This percentage was even higher (60.3%) in the under 5 year old age
group[4]. One theory for the higher incidence among males is that males report more
unsafe food-handling practices and higher consumption of finger foods that are known to
increase the risk for foodborne diseases[237, 238]. This, however, does not explain the
sex difference observed in young children where the risks should be similar, due to
similar hygiene and diet at this age.
A descriptive study of FoodNet sites in the United States also found that the
highest incidence of campylobacteriosis was reported in infants less than 1 year (56.2 per
100.000) followed by children aged 1-4 years (41.2 per 100,000)[239]. This study also
reported a smaller peak in the incidence in the population aged 20-29 (30.3 per 100,000).
As seen in other countries, males had a higher average incidence of infection (24.4 per
100,000) than females (19.4 per 100,000). Other studies in the United States have also
reported a higher percentage of males[195, 198]. A case-control study of the FoodNet
sites found 54% of cases enrolled in the study were male[198] and a study in Colorado
found 61.7% of campylobacteriosis patients were male[195]. Both case-control studies
noted that there was no significant difference in the sex of the patients who participated
in the study compared to those who didn’t participate in the study. Overall in the United
States the highest incidence is observed in the young children, and there is a slight
predominance of males in most studies.
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2.10.2.2

Temporal Patterns

Worldwide the reported incidence of campylobacteriosis spikes during the
summer months. This trend has been noted in both the Northern and Southern
hemispheres. In Denmark the highest incidence of disease occurs from July to September
[236]. In a New Zealand study of recreational water isolates and human disease, the
authors found the highest concentration of Campylobacters in water samples during the
summer months, December-February, and also noted a steady increase in incidence of
human disease from winter through summer[68]. Another study in New Zealand found
the highest incidence of human disease during summer and noted that this seasonal
variation was more amplified in the urban areas[240, 241].
In Wales, one study compared the seasonal variation of human Campylobacter
isolates with that from commercial chicken isolates. It reported that the number of
human isolates peaked around weeks 22-25, in early June while the number of chicken
isolates peaked around weeks 24-26, in late June[242]. This June peak is consistent with
the data from the FoodNet study in the US that found increasing infection rates during the
spring and a peak in the rates in June or July[239]. The June/July peak was also
demonstrated by a study in Massachusetts that compared the incidence of disease with
the ambient temperature[243]. This study found that the peak in the incidence of
campylobacteriosis coincided with the peak in the ambient temperature and it occurs on
average around day 208, in late June. A similar trend was observed in Michigan, with
more cases being reported in the summer, especially in rural areas that have a high
poultry density[232].
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2.10.2.3

Geographic Distribution

The geographic distributions are not as consistent worldwide; some studies have
reported higher incidence in rural areas while others have reported it in the urban
areas[232, 239, 244]. A study of the spatial distribution in Manitoba found that the
incidence was significantly higher in populations living in rural and agricultural areas of
the province[244]. This study also found that the incidence in young children under 5
was seven times higher in rural Manitoba compared to the city of Winnipeg. A study in
Denmark similarly concluded that living in housing types found in rural areas and living
in areas with a low population density were associated with an increased risk of
infection[245].
In the Netherlands, a 2006 study found the highest incidence in the southern
portion of the country (55.7 per 100,000) compared to the rest of the country (39.1 per
100,000)[236]. When the country was separated into urban and rural, the higher
incidence was observed in the urban areas (41.9 per 100,000) compared with the rural
(32.4 per 100,000). Similar patterns were observed in New Zealand[246]. In the United
States, the highest incidence among the FoodNet sites occurs in the California[239]. The
counties involved in the California site are San Francisco and Alameda counties, both of
which are very urban. Contrary to that report, a study in Michigan that classified areas
into low and high poultry density, found that the higher incidence of campylobacteriosis
was reported in the more rural areas, which have higher densities of poultry[232].
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2.11 Surveillance
The overall goal of surveillance is to collect, record, share and analyze data, and
then disseminate the resulting information to relevant authorities who take action to
control disease. The World Health Organization (WHO) has defined four categories of
surveillance systems for foodborne pathogens: no formal surveillance system, syndromic
surveillance, laboratory-based surveillance, and integrated food-chain surveillance [247].
No formal surveillance system involves investigation of large or unusual
outbreaks which are performed by outside organizations, such as non-governmental
organizations (NGOs). In syndromic surveillance, information is collected on syndromes
without a laboratory confirmed diagnosis. Laboratory-based surveillance collects
laboratory data, and differs from syndromic surveillance because it involves the
identification of the etiologic agents. Integrated food-chain surveillance, involves
collecting data from animals, food and humans in order to provide an overall picture.
The goal is to track the specific pathogen from animal to human. The latter three forms
of surveillance can be either active or passive.
The difference between passive and active surveillance is that passive surveillance
programs wait for the data to be transmitted to the organization while active surveillance
programs rely on information to be transmitted, but the health organizations also
regularly contact health care providers or the public to solicit the information actively.
Active surveillance is more costly but the information is obtained in a more timely
fashion, the data may be more accurate and complete and active surveillance helps to
reduce under-reporting.
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In passive surveillance, reporting can be voluntary or mandatory, and the agency
in charge uses routinely collected data. Enter-net is an international passive surveillance
network for human gastrointestinal infections. Originally created to monitor Salmonella
and E. coli in Europe, Enter-net now gathers some information on Campylobacter from
20 countries in Europe and around the world[248]. The modes of surveillance and
information provided by each country are varied. Some countries have mandatory
reporting but do not seek additional information from patients while the reporting in other
countries is voluntary or only from certain sentinel sites (smaller sampling sites that are
approximately representative of the population studied)[248]. These differences in
surveillance programs make the comparison of the burden of disease for specific
pathogens across countries and across regions within countries difficult. One of the goals
of the network is to develop a consensus on standards for national participation in
international surveillance. Global Salm-Surv (GSS), created by the WHO in 2000 for the
worldwide surveillance of Salmonella, has now started new training programs for the
worldwide surveillance of Campylobacter[249]. In the United States, passive
surveillance of Campylobacter infections was implemented in 1982 and
campylobacteriosis became a notifiable disease. During this time, isolates were reported
through the Public Health Laboratory Information System (PHLIS)[7]. Under this
system, reports of isolates were mailed weekly to the Centers for Disease Control and
Prevention (CDC) from local health departments. These reports only included limited
information since the system did not involve interviewing the patients and cases were not
actively sought. Currently, Campylobacter is not on the list of National Notifiable
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Diseases in the United States[250], but is on the list of notifiable diseases in the state of
Tennessee[251].
In active surveillance, the health officials seek out information instead of waiting
for it to be reported. In the United States, the Foodborne Active Surveillance Network
(FoodNet) is an active surveillance system for all foodborne pathogens, including
Campylobacter. It was created in 1995 to gather more complete information on
foodborne pathogens with the specific goals of determining the burden of foodborne
disease, monitoring trends in the incidence of disease, attributing the burden of disease to
specific foods or settings, and to develop and assess interventions designed to reduce the
burden of disease[252]. Seven states and parts of three other states, participate in this
network which requires the mandatory reporting of all laboratory confirmed cases. In
1999, 11 counties in Tennessee joined FoodNet[253] and the rest followed suit in
2003[254]. All laboratories in the participating areas, must report any positive laboratory
results for foodborne diseases to their local health departments. Depending on the state
and laboratory, some cultures are sent to the state laboratory for speciation. The local
heath department conducts an interview with each patient to collect demographic and risk
factor information. The major differences between FoodNet and the previous PHLIS
system are the follow up on each patient by the health department to collect additional
information and the requirement that health officials must routinely audit the laboratories
to ensure that all positive results were indeed forwarded to the health department[255].
Compiled data is electronically submitted to the state health department and CDC daily.
The CDC then monitors nationwide spatial and temporal patterns.
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One of the major problems with all surveillance schemes, especially passive
systems, is under-reporting. In order for a case to be reported the person must go through
approximately 7 steps (see Figure 2.1)[252]. At each step the percentage of infected
individuals who continue onto the next steps is diminished. At the bottom of the pyramid
are all the people who are exposed to Campylobacter, but then the patient must develop
symptoms, see their doctor, provide a stool sample and have the organism isolated and
reported. At each of these steps there are number of factors that might influence whether
a patient continues onto the next step: health insurance, perceived severity of the
symptoms, distance to the nearest diagnostic laboratory, fulfillment of stool sample
request and thoroughness of the laboratory. In countries where health care is not
universal, the second step may be the biggest detriment to a case being reported, the
symptoms must be severe enough for the individual to seek medical care. The factors that
influence reporting may also explain some of the distributions observed, since parents of
young children are more likely to take them to the doctor, so children will be most
represented in the database. One goal of FoodNet is to reduce the number of patients that
are lost at each step by actively seeking reports from the laboratories and monitoring the
reporting process (each event that occurs along the pyramid). This allows for a more
accurate and precise estimate of the burden of foodborne disease. In Salmonella it has
been estimated that for every case that is reported, 38 go unreported[256]. Using some of
assumptions used to estimate the true incidence of Salmonella and applying similar
mathmatical equations to the data for Campylobacter, it has been estimated that
1,400,000 to 2,453,926 cases of campylobacteriosis occur annually in the US[3, 239].
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Figure 2.1: Burden of disease pyramid to describe the steps a campylobacteriosis
patient must go through before the case is reported to the health department
(Adopted from: Hardnett, F.P., 2004)
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3.0 Materials and Methods
3.1

Study Area
This study was carried out in sixteen counties in the Eastern portion of the state of

Tennessee (Figure 3.1, Map A). The selected counties are served by two health
departments: the East Tennessee Regional Health Department serves fifteen counties,
while Knox County maintains it own health department (Figure 3.1, Map B). The major
cities in the study region are Knoxville, La Follette, Maryville, Morristown, Oak Ridge,
Pigeon Forge, and Sevierville. The Tennessee portion of the Great Smokey Mountains
National Park and the Big South Fork National River and Recreation Area are also
located within the boundaries of this area. Many lakes and rivers are spread throughout
the area including Watts Bar, Fort Loudon, Chilhowee, Tellico, Douglass, Cherokee and
Norris Lakes, the Tennessee and Big South Fork Rivers and the Melton Hill Reservoir.
Numerous recreational activities are available on these bodies of water, which may have
implications for the transmission of campylobacteriosis.

3.1.1 Climate
The area has a humid subtropical climate that is characterized by hot and humid
summers and chilly to mild winters. In Knoxville, the average high/low temperatures are
88°F/69°F in the summer and 46°F/29°F in the winter, the record high temperature is
103°F, while the record low is -24°F. In the higher altitudes of the Smokey Mountain
National Park, average temperatures range from -20°F to 50°F in the winter with snow
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Map A

Map B

Figure 3.1: The 16 counties involved in the study of campylobacteriosis from 20032006 (map A) and the two participating health departments serving the counties
(map B)
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accumulation, and summer temperatures do not rise above 80°F. The average
precipitation in Knoxville ranges from less than 3” per month during autumn to more
than 5” per month during spring. In the winter, the higher elevations of the Smokey
Mountains average 8” of rainfall and 20” of snow per month, while autumn months
average 5” of precipitation per month. The climate in Knoxville is similar for all 16
counties in the study area.

3.1.2 Population
The population in the study region was approximately 1,045,400 as of the 2000
US census. The region has a mixture of urban and rural areas. The US Census defines an
urban area as all territory, population and housing units located within areas designated as
urbanized areas (population greater than 50,000) or urban clusters (population less than
50,000)[257]. Urbanized areas and urban clusters consist of the census blocks where the
population density is at least 1,000 people per square mile, the surrounding census blocks
where the population density is at least 500 people per square mile and any census blocks
that may connect these clusters. The most populous county is Knox County which had
about 382,000 residents in the 2000 census while Union county is the smallest county
with only 17,800 residents in 2000. Using United States census definitions for urban and
rural, there are some counties (Grainger and Union) where none of the population lives in
an urban area, while in Knox County 87% of the residents are considered to live in an
urban area. At the census county division (CCD) and census tract level, there are some
census tracts and CCDs where 100% of the population is considered to live in an urban
area. These are found in Anderson, Blount, Hamblen and Knox Counties. Census tracts
are small, relatively permanent statistical subdivisions of a county that are delineated by
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the U.S. Census Bureau; the optimum size of each tract is 4,000 people but the population
may be between 1,500 and 8,000 people [258]. A CCD is a county subdivision that has
been delineated by the U.S. Census Bureau in cooperation with state and local officials
for the purposes of presenting statistical data that is generally larger than a census tract
but smaller than a county.
The population density in the study region ranges from 38 persons per square mile
in Morgan County to 751 persons per square mile in Knox County. Examining
population density at the census tract level, the highest densities are 9173 and 7832
persons per square mile in Knox County in two census tracts located near the University
of Tennessee. The lowest population densities occur in Claiborne County in a census
tract with 14 persons per square mile and one in Cocke County with a density of 16
persons per square mile.

3.2
3.2.1

Data Sources
Campylobacter Case Data
Campylobacteriosis data collected from January 2003 through December 2006 by

the East Tennessee Regional and Knox County Health Departments were obtained for
this study. Campylobacteriosis has been a notifiable disease in the state of Tennessee
since 2003 as a result of the state’s participation in FoodNet. Participation in the
FoodNet active surveillance system requires that any positive laboratory
diagnosis/identification of Campylobacter spp. be reported to the local health
department[259]. Tennessee is one of 10 states participating in this network and as such
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laboratories and physicians are required by Tennessee law (Tennessee Code Annotated
68-10-101) to report any Campylobacter positive laboratory results[251] (either stool
culture or serologic tests). The campylobacteriosis case definition for this study was
adapted from the FoodNet definition. Thus, a case of campylobacteriosis was defined as
someone who resides in one of the 16 counties in the study area who was ill, and had a
positive laboratory test result for Campylobacter spp. from either stool culture or
serologic tests.
Once a case is reported, a representative from the health department contacts the
patient to follow up and administer a standardized questionnaire to obtain information on
patient demographics, clinical symptoms and possible exposures, (see Appendices A1-A2
for list of information collected by health departments). Most of the information
collected is entered into an electronic database and electronically submitted, via the
National Electronic Disease Surveillance System, to the Tennessee State Health
Department and CDC in real time. The datasets used in this study were requested and
obtained from the Tennessee State Health Department by each participating health
department that then provided to the study investigators. Additional information not
included in the original electronic database, but present on the health department paper
case report forms was added to the dataset by the investigators (see Appendix A3).
The investigators signed data-user agreements with both participating health
departments to keep the identification information for each patient in the dataset secure
and confidential. Identifiers (name, address and phone number) were removed from the
dataset prior to analysis. This study was approved for research involving human subjects
by the University of Tennessee Internal Review Board (approval # 7634B). In order to
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limit the possibility of patient identification from the plots of the geographic distribution
of cases, geographic analysis was limited to data aggregated at the census tract, CCD,
county and region levels.

3.2.2 Demographic and Socio-economic Data
The population data for each county, CCD and census tract were obtained from
the 2000 census to serve as the denominators for the calculation of the prevalence of
campylobacteriosis. Age- and sex-specific populations were also obtained from the
census in order to calculate age- and sex-specific prevalence proportions. The same
population was used as the denominator for all 4 years of the study since the population
increases proposed by the postcensus estimates were small. The percentage of the
population living in an urban area (urbancity) was also obtained from the 2000 census at
the county, CCD and census tract level. Additionally the total population of the United
States, grouped by age and sex, was downloaded from the 1990 census to use as the
standard population for standardization of the prevalences in this study. The 1990
population is used to standardize the prevalence in the population because the 2000
census population was already part of the calculation of the crude prevalence.

3.2.3 Geographic Data
In order to perform geographic analyses, shape files (also called cartographic
boundary files) were obtained from the Topologically Integrated Geographic Encoding
and Referencing (TIGER) files on the U.S. Census Bureau website
(http://www.census.gov/geo/www/cob/bdy_files.html). TIGER files are the automated
format that is used by the U.S. Census Bureau to describe land attributes and areas.
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These shape files were obtained at different geographic scales: state, county, CCD and
census tract. The map data were merged (based on the county, CCD or census tract) with
the demographic census data in order to analyze spatial patterns and associations between
the geographic location and the prevalence of campylobacteriosis. The area of each
polygon (county, CCD and census tract) was also obtained from the TIGER files. Area
on the census website is provided in square meters and was converted to square miles.
This area information was used to calculate human population densities which were
investigated for the potential association with the prevalence of campylobacteriosis.

3.3

Evaluation of Campylobacter Data Quality
The quality of the electronic datasets provided by each health department was

assessed by evaluating a random sample of 20% of the cases in each dataset. The random
number generator function “RANDBETWEEN” of Microsoft Excel version 2003
(Microsoft, Redmond, WA) was used to randomly select the cases for analysis. For each
health department and each year of the study, the data quality evaluation involved the
assessment of the completeness and accuracy of data entry. When comparing each
patient’s paper case report form with their record in the computer dataset, the paper case
report form was considered the gold standard. If the variable field in the computer record
was blank, but information was included on the case report form, this lack of data was
considered an incomplete data entry or missing information error. For the purpose of
evaluating the dataset, all omissions were counted as errors, since it is impossible to
know which omissions are due to inadvertent oversight, data loss during conversion, or
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purposeful exclusion. A data accuracy error was defined as a discrepancy between the
paper case report and the computer record. For both classes of errors, after the error was
noted, the computer record was corrected before further analyses were performed. After
the data quality assessment was complete, the other 80% of the computer records were
corrected for errors as well. Due to variations in the computer databases used by the
state of Tennessee during the study, and a change in the case report form, the number of
variables analyzed varied by year, (see Appendix A4 for variables included in the dataset
each year).

3.4

Data Manipulations
New variables were created based on the information obtained in the case report

forms. These variables (see Appendix A5) were used to investigate potential associations
with the prevalence of campylobacteriosis. The patients were divided into 6 groups
based on their age: under 5, 5-14, 15-29, 30-49, 50-64, and 65 and over. This
classification was selected to correspond with the available groupings in the 1990 and
2000 censuses. Patient age groups were also selected based on other factors such as
grade school attendance, and the normal work and retirement age and the epidemiology
of campylobacteriosis (highest prevalences reported in children under 5 [239]). To assess
differences in care seeking behaviors of different population groups (age group and
geographic location), the variable “time waited before seeking medical care” was created.
This variable was calculated based on the difference between the date the patient reported
the onset of their symptoms and the date of the stool culture submission (considered by
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the health department to be the diagnosis date.) Similarly, to determine if patients in East
Tennessee differed in the length of stay in the hospital, the number of days in the hospital
was calculated from the hospital admission and discharge dates.
To compare the severity of disease among different groups (age or geographic
location) of campylobacteriosis patients in this study, a severity of disease score was
calculated. The scale used to establish the severity of disease is shown in Table 3.1,
which was adopted from a similar scale developed by investigators in a Canadian
study[260]. The possible severity scores can range from 0-16 and were grouped into the
following categories: mild 1-7, moderate 8-11 and severe ≥12. Additionally, the 16
counties in this study were divided into 4 groups based on the urbanicity (percentage of
the population living in an urban area) in each county. Counties were grouped based on
the urbanicity of the county in order to assess if the prevalence of campylobacteriosis, the
symptoms experienced or the potential risk factors reported were associated with urban or
rural areas. The groupings were determined by dividing the total range of urbanicity
values (0-87%) by 4, and using this value (22%) as the break point, so the same range of
urbanicity values are present in each group. The county groupings are shown in
Appendix B1.
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Table 3.1: Scale used to assess the severity of campylobacteriosis in patients from a
16 county region in East Tennessee, 2003-2006
Variable
Response
Points Assigned
Duration
<2 days
1
3-5 days
2
6-10 days
3
11-14
4
>15 days
5
Bloody Stool
No
0
Yes
3
Fever
No
0
Yes
2
Cramps
No
0
Yes
1
Nausea
No
0
Yes
1
Vomitting
No
0
Yes
1
Muscle Aches
No
0
Yes
1
Fatigue
No
0
Yes
1
Headache
No
0
Yes
1
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3.5

Statistical Analysis

3.5.1 Summary Statistics
Demographic and clinical characteristics together with risk factor variables were
summarized to describe the overall characteristics of the study population. Frequency
distributions were computed for categorical variables (Table 3.2) and reported as the
percent of patients with the characteristic of interest. Binomial 95% confidence intervals
around the percentages were also computed. Missing or unknown values were excluded
from these computations. The treatments reported were categorized by the type of
treatment received, and class of antibiotic, if applicable. Proportions were also calculated
for treatment types. Patients were included in more than one category if they were
prescribed multiple classes of antibiotics or classes of treatments. The normality of
continuous variables (duration of disease, age, severity of disease, time hospitalized, and
time waited to seek medical care) was assessed using the Shapiro-Wilk test statistic.
Median and range were computed for variables that did not conform to a normal
distribution (duration, age, time hospitalized, and time waited). The mean and standard
deviation were used to summarize variables with a normal distribution (severity of
disease). Each summary statistic was calculated for the entire study region, each county,
each year, each age group, and each urbanicity grouping. Differences in medians were
tested using the Kruskal-Wallis and Mann-Whitney U tests. All above calculations were
performed using SAS version 9.1 (SAS Institute, Cary, NC).
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Table 3.2: Categorical variables summarized with patient proportions for campylobacteriosis in a 16
county region of East Tennessee, 2003-2006

Categorical variables analyzed
Age group
Animal exposure
Contact with other sick individuals
Drink untreated water
Handled raw meat
Hike, camp or swim
Household member in daycare
Patient died
Patient hospitalized
Prevalence group
Race
Severity of illness
Serotype
Specimen source
Symptom variables
Test ordered
Travel
Treatment information
Urbanicity group
Water source
Where treatment sought
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3.5.2 Assessment of Statistical Associations
To assess differences in the distribution of clinical characteristics, potential risk
factors, or treatments among different patient groups, the percentages calculated for each
variable above, were compared across groups. The groups included in these analyses
were age category, sex, hospitalization status, season, location of where medical care was
sought, if an antibiotic was prescribed, urbanicity group, and prevalence group. Possible
associations between these variables and clinical and potential risk factor variable were
compared across the different strata of each variable. Additionally when comparing the
age groups, the under 5 age group was also compared to the rest of the study population
over 5 years old. Clinical symptom variables were compared for statistical associations
in order to identify combinations of symptoms that were often reported together.
Categorical variables were compared using Fisher’s Exact test, (for 2x2 comparisons) and
Pearson χ2 test (for larger tables) in SAS. Overall test p value ≤0.05 was considered
significant. Associations were presented as odds ratios with a 95% confidence interval.
When a variable had multiple categories, one was selected as the reference group which
was compared with all other groups of that variable. The reference group selected for
comparisons was either the first or last group of the variable and the one with the larger
proportion of patients in the group.

3.5.3 Prevalence Calculation and Standardization
The crude average annual prevalence of campylobacteriosis was calculated for
each county by dividing the average case count over the four year study period by the
total population for each county. The average case count was calculated taking the total
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number of cases reported in each county over the four year study period and dividing by
4. The 2000 census was used as the population for the denominator in all four years of
the study. The resulting prevalence was then multiplied by 100,000 to express the
prevalence as cases per 100,000 persons.
The prevalence proportions for each county and CCD were age- and sexstandardized using the direct method and the 1990 total United States population was
used as the reference population. Standardization was performed using the “dstdize”
command in Stata version 10.0 (Stata Corp., College Station, TX). The standardized
prevalence proportion was calculated to remove the influence of age and sex in different
populations. This allows for the comparison of the prevalence of campylobacteriosis
between counties in the study region and the comparison with the reported prevalence of
other states that have been similarly standardized.
After the standardized prevalence for each county was calculated, the counties
were divided into 4 groups based on this prevalence. The groupings used were 0-6 cases,
6-12 cases, 12-18 cases and 18-24 cases per 100,000 persons. The groupings by county
are shown in Appendices B2 and B3. These groupings were determined by dividing the
maximum prevalence in the region (23 cases/100,000) by 4, so 6 cases per 100,000 was
used as the cut point in creating the groups. These groups were created to assess
differences in the reported potential risk factors, and clinical characteristics based on the
standardized prevalence.
Mean annual age-specific, sex-specific and age- and sex-specific prevalence
proportions were also calculated. Exact confidence intervals for the prevalence
proportions were calculated in Stata. Comparisons of the prevalence proportions across
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age groups, sex, or sex and age group were performed using the “prtesti” command in
Stata for comparing two proportions. Simes method was used to adjust for multiple
comparisons. Overall test p value ≤0.05 was considered significant.

3.5.4 Geographic Analysis
GPS (Global Positioning System) coordinates were obtained for each patient
using the home address provided on the case report form. These addresses were
geocoded using GPS Visualizer (www.gpsvisualizer.com). The geocoding was
conducted at the health department before the data were released to the investigator to
ensure that potentially identifying patient information did not leave the health department
premises. Point-in-polygon technique of GIS (Geographic Information System) was used
to join the GPS coordinates of the address of each case to the county, CCD and census
tract map layers, using ArcView GIS 9.2 (ESRI Redlands, CA). This procedure
geographically plotted each case in the appropriate county, CCD or census tract based on
the geographic location. After plotting, the sum of the total number of cases reported in
each county or CCD was calculated. This sum was used to calculate the prevalence for
each county. These area specific prevalences were displayed in ArcView GIS, in order to
identify areas of high risk. The CCDs were also grouped into 11 groups by urbanicity
(0%, 10%, 20%…100%). The group specific prevalence proportions were calculated, as
described above (section 3.5.3). Exact 95% confidence intervals were calculated in Stata
around each prevalence proportion so as to compare the prevalence proportions for each
urbanicity grouping of the CCDs.
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3.5.5 Temporal Analysis
The annual prevalence estimates of campylobacteriosis were calculated for each
year, as described in section 3.5.3. In order to compare the prevalence of
campylobacteriosis in East Tennessee region with the state of Tennessee and all of the
FoodNet sites, the annual case counts of reported cases of campylobacteriosis in
Tennessee and all of FoodNet were obtained from FoodNet reports[20, 261-265]. The
annual prevalence for each year, 2003-2006, was also calculated for the state of
Tennessee and all the sites of the FoodNet surveillance program using postcensus
estimates for the denominator. These were the populations described in the published
reports that were used the denominator for prevalence calculation. The monthly
prevalence of campylobacteriosis in East Tennessee was calculated for each of the 48
months in the study. Moving averages were calculated over a 3 month period to smooth
out any short-term fluctuations in the prevalence, and highlight the overall trends or
cycles. Additionally, the average number of cases occurring in East Tennessee in each
calendar month was calculated and the average monthly prevalence determined. In order
to assess broader seasonal trends, the months were aggregated into seasons (Spring:
March, April, May; Summer: June, July, August; Fall: September, October, November;
Winter: December, January, February). The average case count was calculated for each
season and used as the numerator to calculate the average seasonal prevalence. The 95%
confidence intervals for each of the prevalence proportions described above were
computed. Comparisons of these prevalence proportions between years and season was
also performed as described under section 2.5.3.
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4.0 Results

4.1

Data Quality
Among the 20% subset of cases (79 cases) that were randomly selected, the

overall error rate (data accuracy and missing information errors combined) was 6.5%
(128/1960). Data accuracy errors comprised 46.9% (60/128) of the total errors, while
incomplete data entry or missing information errors comprised the other 53.1% (68/128)
of the errors identified. The inaccuracy error rate was 3.0% (60/1960) while the missing
information error rate was 3.4% (68/1960). There were some common errors between
the health departments. Inaccuracy errors identified in both health departments’ datasets
were found in the following variables: diagnosis date, zip code and ethnicity. Missing
information errors common to both health departments’ datasets were observed in:
address, zip code, ethnicity and race.
The overall error rate for the East Tennessee Regional Health Department
(ETRHD) was 4.7% (51/1090); 70.6% (36/51) of the errors were in data accuracy and
29.4% (15/51) were missing information errors. For the Knox County Health
Department (KCHD), the overall error rate was 8.8% (77/870), with 31.2% (24/77) of the
errors in data accuracy and 68.8% (53/77) were missing information errors. The overall
KCHD error rate was significantly (p=0.0002) higher than that of the ETRHD. Table 4.1
shows the error rates for each health department and year.
The most common variables with errors for the ETRHD were “ethnicity” (13
inaccuracies and 2 cases with missing information), and “source of the specimen tested”
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Table 4.1: Data quality evaluation of 20% sample of 8 campylobacteriosis datasets from East Tennessee Regional and
Knox County Health Departments, 2003-2006
Health
Year Number of Cases with
Total # of
Overall error
Inaccuracy
Percentage of
Department
variables in errors/Cases
fields
percentage
error
missing
dataset
analyzed (%)
analyzed
(total # errors) percentage
information errors
(# of
(# of incomplete
inaccuracies)
entries)
2003 22
6/16 (37.5)
352
4.26 (15)
3.41 (12)
0.85 (3)
East
Tennessee 2004 24
10/13 (76.9)
312
8.33 (26)
4.83 (17)
2.88 (9)
2005 28
7/12 (58.3)
336
2.98 (10)
2.08 (7)
0.89 (3)
2006 28
0/4 (0)
112
0
0
0
2003 24
8/11 (72.7)
264
5.68 (15)
3.03 (8)
2.65 (7)
Knox
County
2004 24
8/8 (100)
192
18.2 (35)
6.25 (12)
12.0 (23)

2005 28
2006 28

7/7(100)
6/8 (75)

196
224

9.18 (18)
4.02 (9)

0.51 (1)
1.34 (3)

8.67 (17)
2.68 (6)
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(10 inaccuracies and 1 case with missing information). The most common inaccuracy
errors in the ETRHD dataset included listing an ethnicity when none was specified on the
case report form, or listing the blood as the specimen when stool was specified on the
case report form. Other variables with inaccuracy errors identified only in the ETRHD
datasets, included: city, county, zip code, race, diagnosis date, source of report, whether
the patient was hospitalized, hospital name, the date of discharge from the hospital and
the status of the patient (hospitalized or outpatient). Variables with missing information
errors in the ETRHD datasets were: serotype, race, address, zip code, and city. The 2006
analysis was performed partway through the year so only 4 cases were evaluated for data
quality, and no inaccuracies or missing information were observed (Table 4.1).
For the KCHD, the most common variables with errors were ethnicity (8 errors in
data accuracy and 6 missing information errors) and travel (3 errors in data accuracy and
8 missing information errors). Other variables with errors in accuracy identified only in
the KCHD datasets were: diagnosis date, zip code, street address, the hospital discharge
date and patients outcome (alive or dead). Variables that had missing information in the
computer dataset were: home phone, physician name, street address, zip code, race, travel
dates, and middle name.
Table 4.2 shows the percentage of missing or unknown values for each variable in
the corrected dataset. Certain variables have a higher percentage of unknowns due to a
change in the data collection form. For example, the “household drinking water source”
and the “location where the patient sought medical care” fields were removed from the
new case report form introduced in 2006. Additionally, the question about treatment was
changed from “any treatment received” to “any antibiotic given”. The wording about
66

Table 4.2: Percentage of patients with missing or unknown information for each
variable in the corrected campylobacteriosis dataset from a 16 county region in East
Tennessee, 2003-2006 (n=436)
Variable
Number of missing or unknowns values(%)
Race
22 (5.0)
Specimen source
7 (1.6)
Serotype
214 (49.1) *
Test ordered
28 (6.4)
Patient hospitalized
4 (0.9)
Patient died
111 (25.5)
Symptom variables
39 (8.9)
Where treatment sought
228 (52.3) †
Travel
37 (8.5)
Animal exposure
36 (8.3)
Handled raw meat
58 (13.3)
Household member in daycare 40 (9.2)
Contact with other sick
48 (11.0)
Hike, camp or swim
40 (9.2)
Drink bad water
51 (11.7)
Water source
172 (39.4) ‡
Treatment information
126 (28.9)
*

Serotype not identified, listed as Campylobacter spp.
81 unknown, 147 not on case report form
‡
5 unknown, 167 not on case report form
†
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drinking untreated water was changed as well from “Drink from a spring, stream, or
lake?” to “Did the patient drink untreated water in the 7 days prior to onset of illness?”
These changes led to a larger percentage of unknowns in the corrected 2006 dataset
compared to other years.

4.2

Descriptive Statistics

4.2.1 Demographic Characteristics of Patients
A total of 436 cases of campylobacteriosis were reported in the 16 counties over
the 4 year study period. The median age of all cases was 26 (range 1 month to 89 years).
There was no significant (p=0.08) difference in the median age of the cases across all
years of the study. The majority of cases (53.7%, 234/436) were male; the median age
for males was 23.5 while the median age for females was 30.5, but this difference was
not statistically significant (p=0.155). Most cases (95.6%, 396/414) were classified as
white. Only 3.9% occurred in children aged 6 months or younger, but 15.4% occurred in
children aged 1 year or younger. Males accounted for 59% of the under 5 age group,
60.7% of the cases in the 5-14 age group but only 42.9% of the cases in the 65 and over
age group.
There was a significant (p=0.0004) difference in the median age of patients when
the counties were grouped based on urbanicity (Table 4.3). There was also a significant
(p=0.0210) difference in the median age of the patients when the counties were grouped
based on disease prevalence. Although the median age is lower in the rural and higher
prevalence counties, the percentage of the population that is under 5 years old is not
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Table 4.3: Distribution of campylobacteriosis cases based on the prevalence of
disease or the percentage of the county that is considered urban in a 16 county
region in East Tennessee, 2003-2006 (n=436)
Grouping
No of
Percentage of
Median
Crude Group
Variable
cases (%) population under age
Specific
5 years of age
Prevalence
Urbanicity Group
66% or more
184 (42.2) 6.2
31.5
10.4
44-66%
116 (26.6) 5.7
31.0
10.8
**
22-44%
102 (23.4) 6.0
16.5
8.9
22% or less
34 (7.8)
6.4
5.5**
10.7
Prevalence Group
0–6*
25 (5.73)
6.3
24.0
6 – 12
268 (61.5) 6.1
29.0
12 – 18
90 (20.6)
5.9
26.5
18 – 24
53 (12.2)
6.1
8.0‡
*
Listed as cases per 100,000 population
- Not applicable
**
Significantly different (Simes corrected p=0.025)
‡
Group 4 (18-24) is significantly different from group 2 (6-12)
(Simes corrected p=0.0083)
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significantly different among the counties. The median age also varied greatly among the
16 counties in the study. The county with the lowest median age (3) was Cocke County,
while Hamblen County had the highest median age (39 years) (Table 4.4).

4.2.2 Care Seeking and Diagnostic Characteristics
The median delay in seeking a physician’s care from the onset of symptoms
reported by patients was 4 days (range = 1 – 181 days). Most patients either sought care
at a doctor’s office (46.6%, 97/208) or an emergency room (ER) (47.6%, 99/208), (Table
4.5). Most (99.5%, 427/429) patients submitted a stool sample (Table 4.5) and stool
culture was the predominant test ordered (93.4%, 381/408), but additional laboratory tests
were ordered in some cases. The species of Campylobacter was identified in 50.9%
(222/436) of cases. The most commonly identified species was Campylobacter jejuni
(98.7%), followed by 2 cases of C. coli (0.9%) and the co-infection of C. jejuni and C.
coli in 1 case (0.45%). Twenty-five percent of cases had missing information regarding
the disposition (alive or deceased) of the patient after infection with campylobacteriosis,
but of those with known information, 1 patient died.

4.2.3 Clinical Description of Cases
The most common clinical symptoms and signs reported were: diarrhea (97.5%),
fever (62.5%), cramps (56.2%) and nausea (47.4%), (Table 4.6). Specific combinations
of symptoms tended to occur in some patients. Those patients who reported nausea
(47.4%) were also likely to report vomiting (38.5%); 25.9% reported both (χ² =39.8026,
p=<0.0001). Patients who reported suffering from headaches were also likely to report
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Table 4.4: Median age of cases reported in each county in a 16 county region in East
Tennessee, 2003-2006
County
Median age of cases
Range of ages reported
reported
Anderson
38*
1 – 65 years
Blount
30.5
7 months – 74 years
Campbell
33
10 months – 70 years
Claiborne
23
1 month – 87 years
Cocke
3
1 month – 75 years
Grainger
6
2 months – 58 years
Hamblen
39
6 – 75 years
Jefferson
10
1 month – 84 years
Knox
30
1 month – 89 years
Loudon
30
2 months – 62 years
Monroe
9
7 months – 69 years
Morgan
13.5
1 – 55 years
Roane
15.4
2 months – 39 years
Scott
13.5
1 – 66 years
Sevier
24.0
8 months – 71 years
Union
4.0
1 – 75 years
*
No significant differences were identified between all counties due to the number of
comparisons (120)
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Table 4.5: Physician visit location, laboratory and hospitalization information for
reported cases of campylobacteriosis in a 16 county region in East Tennessee, 20032006
Variable
Number of cases (%)
Location patient sought treatment (n=208)
Doctor’s Office
97 (46.6)
Emergency Room
99 (47.6)
Emergency Room and Doctor’s Office
10 (4.8)
Urgent Care Clinic
2 (1.0)
Source of specimen used to identify Campylobacter (n=429)
Stool
427 (99.5)
Blood
2 (0.5)
Test ordered by physician (n=408)
Culture
381 (93.4)
Culture and Serological
19 (4.6)
Culture and Ova & Parasite
4 (1.0)
Culture, Ova & Parasite and Serological
1 (0.2)
Other
1 (0.2)
Ova & Parasite
1 (0.2)
Serological
1 (0.2)
Campylobacter serotype identified (n=222)
Jejuni
219 (98.6)
Coli
2 (0.9)
Coli and Jejuni
1 (0.4)
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Table 4.6: Self reported clinical signs among patients with campylobacteriosis in a
16 county region in East Tennessee, 2003-2006
Variable
No cases (%)
Symptom (n=397)
Diarrhea
387 (97.5)
Fever
248 (62.5)
Cramps
223 (56.2)
Nausea
188 (47.4)
Vomiting
152 (38.5)
Bloody Stool
150 (37.8)
Fatigue
122 (30.7)
Muscle Aches
122 (30.7)
Headache
106 (26.7)
Chills*
32 (8.1)
Severity (n=374)
Mild (1-7)
179 (47.9)
Moderate (8-11)
158 (42.2)
Severe (≥12)
37 (9.9)
*

Chills as a symptom was not introduced as a check box on the case reports until 2006, but could be added
under “Other” prior to 2006
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fatigue; 15.4% reported experiencing both (χ² =48.8542, p=<0.0001). Other associated
symptoms were cramps and nausea (χ² =48.5601, p=<0.0001) and headache and muscle
aches (χ² =42.2214, p=<0.0001). Fever was a commonly reported symptom with 62.5%
(248/397) of patients reporting experiencing a fever. Not all cases who reported fever
gave the maximum temperature. Only 70.6% (175/248) reported the temperature reading
of the fever. The median high temperature was 102.0°F (range: 99.0 - 105.0°F).
Certain symptoms of campylobacteriosis were significantly associated with the
age of the patient (Table 4.7). The youngest age group (under 5) was used as the
reference group in all comparisons. Bloody stool was the only symptom for which all
older age groups had lower odds of reporting the symptom when compared with the
under 5 age group. For the other symptoms listed above the older age groups were more
likely to report experiencing the symptom. Symptoms were also statistically associated
with the urbanicity grouping of the county where the patient resided (Table 4.8). When,
the most urban category (66-88% urban) was used as the reference group, the more rural
counties had higher odds of reporting bloody stool, nausea, vomiting, cramps, and
fatigue.
The median duration of disease was 7 days (range: 1-60, 180 days); this was the
same for both males and females. There was no significant difference in the duration of
symptoms when the counties were grouped by urbanicity or by the prevalence of disease.
The mean severity of disease score was 7.6 ±3.1 (severity score was normally distributed)
and this was the same for males and females. Patients with a score of 1-7 were
considered mild (47.9%), 8-11 moderate (42.2%) and a score of 12 or more was
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Table 4.7: Odds ratios of statistical associations between disease characteristics and
the age group of the patient in a 16 county region in East Tennessee, 2003-2006
Odds Ratio
Exact p value
Comparison Variable
Age Group*
(Confidence Interval)
5-14 years old
2.9 (1.2-6.7)
15-29 years old
1.0 (0.40-2.7)
30-49 years old
2.1 (0.97-4.4)
50-64 years old
4.4 (1.9-9.7)
65 years and older 11.5 (4.6-28.4)
5 years and older† 2.8 (1.5-5.5)
5-14 years old
0.60 (0.30-1.2)
Bloody Stool (yes)
15-29 years old
0.72 (0.37-1.4)
30-49 years old
0.37 (0.21-0.66)
50-64 years old
0.24 (0.11-0.51)
65 years and older 0.21 (0.084-0.53)
5 years and older
0.41 (0.26-0.66)
5-14 years old
17.1 (3.7-79.6)
Headache
15-29 years old
36.5 (8.2-162.0)
30-49 years old
29.5 (6.9-126.2)
50-64 years old
21.1 (4.6-96.0)
65 years and older 9.5 (1.8-49.7)
5 years and older
24.0 (5.8-99.5)
5-14 years old
3.2 (1.4-7.0)
Nausea
15-29 years old
9.3 (4.4-19.7)
30-49 years old
8.2 (4.2-16.1)
50-64 years old
6.1 (4.6-96.0)
65 years and older 4.6 (2.0-10.8)
5 years and older
6.4 (3.6-11.5)
5-14
years
old
3.2 (1.5-6.6)
Cramps
15-29 years old
7.6 (3.6-15.8)
30-49 years old
6.8 (3.7-12.7)
50-64 years old
3.3 (1.7-6.7)
65 years and older 1.9 (0.83-4.2)
5 years and older
4.5 (2.7-7.5)
5-14 years old
1.8 (0.62-5.4)
Muscle Aches
15-29 years old
6.1 (2.5-14.8)
30-49 years old
9.0 (4.0-20.6)
50-64 years old
10.8 (4.4-26.4)
65 years and older 4.3 (1.5-12.0)
5 years and older
6.4 (3.0-13.8)
5-14 years old
2.2 (0.89-5.6)
Fatigue
15-29 years old
6.4 (2.9-14.3)
30-49 years old
3.6 (1.7-7.6)
50-64 years old
7.0 (3.1-16.0)
65 years and older 3.9 (1.5-10.1)
5 years and older
13.0 (6.7-25.50
*
Reference Group: Youngest age group (under 5 years old)
†
Under 5 age group compared to all groups over 5 years old
Was the patient
hospitalized? (yes)

0.015
1
0.068
0.0004
0.0004
0.0008
0.21
0.33
0.0009
0.0001
0.0006
0.0002
<0.0001
<0.0001
<0.0001
<0.0001
0.005
<0.0001
0.004
<0.0001
<0.0001
<0.0001
0.0005
<0.0001
0.0019
<0.0001
<0.0001
0.0008
0.14
<0.0001
0.26
<0.0001
<0.0001
<0.0001
0.0078
<0.0001
0.09
<0.0001
0.0006
<0.0001
0.008
<0.0001
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Table 4.8: Associations between symptoms of campylobacteriosis and the urbanicity
of the county of residence for a 16 county region in East Tennessee, 2003-2006
Variable
Urbanicity
Odds Ratio
Exact p
Group*
(Confidence Interval)
value
44-66% urban
1.8 (1.1-3.1)
0.025
Bloody Stool
22-44% urban
2.2 (1.3-3.7)
0.0042
0-22% urban
3.2 (1.5-7.1)
0.0053
44-66% urban
2.1 (1.2-3.5)
0.0054
Fever
22-44% urban
1.9 (1.1-3.3)
0.018
0-22% urban
1.2 (0.55-2.6)
0.7
44-66% urban
2.8 (1.6-4.8)
0.0004
Headache
22-44% urban
1.5 (0.83-2.8)
0.2
0-22% urban
1.8 (0.75-4.3)
0.2
44-66% urban
3.6 (2.2-6.0)
<0.0001
Nausea
22-44% urban
1.4 (0.81-2.3)
0.3
0-22% urban
2.6 (1.2-5.6)
0.025
44-66% urban
1.5 (0.90-2.5)
0.15
Vomiting
22-44% urban
2.4 (1.4-4.0)
0.0014
0-22% urban
2.6 (1.2-5.6)
0.02
44-66% urban
3.6 (2.2-6.2)
<0.0001
Cramps
22-44% urban
1.2 (0.72-2.0)
0.5
0-22% urban
4.4 (1.8-10.7)
0.0007
44-66% urban
2.5 (1.5-4.4)
0.0009
Muscle Aches
22-44% urban
2.6 (1.5-4.6)
0.0013
0-22% urban
1.9 (0.83-4.5)
0.15
44-66% urban
6.4 (3.5-12.0)
<0.0001
Fatigue
22-44% urban
5.2 (2.7-9.8)
<0.0001
0-22% urban
6.4 (2.7-15.0)
<0.0001
*
Reference Group: most urban (66-88% urban)
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considered severe (9.9%) as shown in Table 4.6. The majority of the 37 cases in the
severe category were in the 30-49 age group (15/37, 40.5%). The mean severity score
was highest in the 15-29 age group at 8.6 (95% CI: 7.7 - 9.4) and the lowest in the 65 and
over age group at 6.5 (95% CI: 5.3 - 7.6).

4.2.4 Treatment
A wide rage of therapeutic agents were prescribed, namely: broad spectrum
antibiotics, antiprotoazoals and antivirals (Table 4.9). Most (73.6%) patients were
prescribed only 1 therapeutic agent, 15.5% were prescribed 2, 3.2% were prescribed 3
and 7.7% had no therapeutic agent prescribed. Antibiotics were the most commonly
prescribed therapeutic agents with 84.5% of patients reporting receiving at least 1
antibiotic. Of the patients who knew the class of antibiotics prescribed, fluoroquinolones
and macrolides were the two most common.

4.2.5 Hospitalization
Of the 432 cases with known hospitalization information, 101 (23.4%) were
hospitalized. The median length of stay in the hospital was 2 days (range: <1 to 11).
During the 4 years of the study, 2004 had the highest percentage of annual
hospitalizations (26.4%). The annual, seasonal, and monthly hospitalization percentages
are shown in Table 4.10 along with the 95% confidence interval. Among the four
seasons, the highest percentage of hospitalizations was observed in summer 28.4%
(46/162) but this was not significantly different from other seasons. September had the
highest percentage of cases hospitalized at 38.9% (14/36); September and July (30.9%,
21/68) each had a significantly higher monthly percentage hospitalizations than the
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Table 4.9: Treatments reported by campylobacteriosis patients in a 16 county region
of East Tennessee, 2003-2006 (n=310)
Treatment type
No cases reporting treatment(%)*
Antibiotic
262 (84.5)
Β-Lactam
4 (1.5)
Cephalosporin
5 (1.9)
Fluoroquinolone
95 (36.3)
Macrolide
84 (32.1)
Sulfonamide
5 (1.9)
Tetracycline
5 (1.9)
Unknown Antibiotic
73 (27.9)
Intravenous fluids
31 (10.0)
No treatment
18 (5.8)
Antidiarrheal/AntiNausea
14 (4.5)
Antiprotazoal
14 (4.5)
Oral rehydration
6 (1.9)
Other†
11 (3.6)
Number of therapeutic agents prescribed
1 therapeutic agent
228 (73.6)
2 therapeutic agents
48 (15.5)
3 therapeutic agents
10 (3.2)
*

Percentages sum to over 100 since some therapeutic agents were prescribed in combination
“Other” includes: pain drugs (3), proton pump inhibitors (2), steroids (2), appendectomy (2), antiviral (1),
and H2 receptor antagonist (1) (blocks histamine receptor- 2 to decrease stomach acid production)

†
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Table 4.10: Temporal and seasonal proportions of patients hospitalized due to
campylobacteriosis in a 16 county region in East Tennessee, 2003-2006 (n=436)
Time frame
Total number Number of cases
Confidence interval for
of cases (%)
hospitalized (%)
percentage of cases
hospitalized
Year
2003
140 (32.1)
36 (25.7)
18.7-33.8
2004
110 (25.2)
29 (26.4)
18.4-35.6
2005
97 (22.2)
21 (21.6)
13.9-31.2
2006
89 (20.4)
17 (19.1)
11.5-28.8
Season*
Summer
162 (37.2)
46 (28.4)
21.6-36.0
Fall
103 (23.6)
21 (20.4)
13.1-29.5
Winter
91 (20.9)
18 (19.8)
12.2-29.4
Spring
80 (18.4)
18 (22.5)
13.9-33.2
Month
January
26 (6.0)
2 (7.6)
9.4-25.1
February
29 (6.6)
5 (17.2)
5.8-35.8
March
27 (6.2)
7 (25.9)
11.1-46.3
April
24 (5.5)
6 (25.0)
9.7-46.7
May
29 (6.6)
5 (17.2)
5.8-35.8
June
48 (11.0)
14 (29.2)
17.0-44.1
July
68 (15.6)
21 (30.9)**
20.2-43.2
August
46 (10.6)
11 (23.9)
12.5-38.8
September 36 (8.3)
14 (38.9)**
23.1-56.5
October
29 (6.6)
5 (17.2)
5.8-35.8
0.6-17.7
November 38 (8.7)
2 (5.3)**
December 36 (8.3)
11 (30.6)
16.3-48.1
*

Seasons were defined as, Summer: June, July, August, Fall: September, October, November, Winter:
December, January, February, Spring: March, April, May
**
June and September significantly differed from November
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month of November (5.3, 2/38), which had the lowest percentage of hospitalized
campylobacteriosis patients.
The oldest age group (65 and above) experienced the highest percentage of
hospitalization (60.0%), followed by age groups 50-64 (36.2%) and 5-14 (27.3%). The
lowest percentages of hospitalizations were observed in the under 5 age group (11.5%),
followed by 15-29 (11.9%) and 30-49 (21.2%). Hospitalization proportions were
significantly associated with age (p=<0.0001). Using the under 5 age group as the
reference group, these associations are shown in Table 4.7. All groups except the 15-29
age group had significantly higher odds of being hospitalized than the under 5 age group.
Patients over 5 years old had much higher odds of hospitalization than those under 5
(OR: 2.8, CI: 1.5-5.5). The most rural counties had the lowest percentage of cases
hospitalized at 12.0% (4/34; CI 3.3 – 27.4), while the counties that were 44-66% urban
had the highest percentage of cases hospitalized at 29.6% (34/115; CI 21.4 – 38.8%).
This difference was statistically significant (p=0.036).

4.2.6 Risk Factors for Campylobacteriosis
Exposure to animals was the most commonly reported risk factor with 74.2% of
cases reporting being exposed to one or more animals in the week (up to 10 days) prior to
the onset of symptoms (Table 4.11). Of those exposed to animals, the most common
animal was dogs (79.5%) and the least common was turkeys (0.7%). Animal exposure
was significantly associated (p=0.0041) with the age group of the patient, with patients in
the 65 and older age group having significantly lower odds of reporting animal exposure
than the under 5 year old patients (Table 4.12). None of the other age groups had
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Table 4.11: Exposure to suspected risk factors for acquiring campylobacteriosis in
the 10 days prior to symptom onset as reported by patients in a 16 county region in
East Tennessee, 2003-2006
Risk Factor
No of cases (%)
Any animal exposure (n=400)
297 (74.2)
Specific animal exposure (n=297)
Cats
98 (33.0)
Cattle
17 (5.7)
Chickens
29 (9.8)
Dogs
236 (79.5)
Goats
11 (3.7)
Horses
4 (1.4)
Lizards
4 (1.4)
Rodents
13 (4.4)
Turkeys
2 (0.7)
Turtles
4 (1.4)
Handle raw meat/poultry (n=378)
80 (21.2)
Have a household member in daycare (n=394)
33 (8.4)
Have contact with someone with similar symptoms (n=388) 57 (14.7)
Hike, camp, fish or swim (n=394)
75 (19.0)
Drink from a spring, stream, or untreated water (n=385)
40 (10.4)
Travel (n=399)
86 (21.6)
Destination –International
45 (11.3)
Destination – Domestic
41 (10.3)
Water source (n=262)
City
172 (65.7)
Well
82 (31.3)
Spring
8 (3.1)
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Table 4.12: Odds ratios of statistical associations between risk factors for
campylobacteriosis and the age group of the patient, in a 16 county region in East
Tennessee, 2003-2006
Risk Factor
Age Group*
Odds Ratio
Exact
(95% Confidence Interval) p value
1.9 (0.72-5.1)
0.26
Animal Exposure (yes) 5-14 years old
15-29 years old
0.99 (0.45-2.2)
1
30-49 years old
0.75 (0.39-1.4)
0.42
50-64 years old
0.54 (0.26-1.1)
0.12
65 years and older
0.29 (0.13-0.66)
0.004
5-14 years old
1.0 (0.72-5.1)
1
Handle Raw Meat
15-29 years old
10.0 (3.2-31.6)
<0.0001
30-49 years old
12.8 (4.3-37.9)
<0.0001
50-64 years old
9.4 (2.9-30.0)
<0.0001
65 years and older
2.8 (0.66-11.9)
0.22
0.59 (0.18-1.9)
0.58
Household Member in 5-14 years old
15-29 years old
0.22 (0.048-1.0)
0.049
Daycare
30-49 years old
0.94 (0.41-2.2)
1
50-64 years old
0.056 (0.0032-0.96)
0.002
65 years and older
0.19 (0.024-1.5)
0.11
*
Reference group: Youngest age group (under 5 years old)
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significant associations with animal exposure when compared with the reference age
group.
International travel was reported by 52.3% of patients reporting travel, while the
other 47.7% reported domestic travel. Travel outside the area of residence was
significantly associated with the age of the patient (p=0.0055), the urbanicity of the
county (p<0.0001), and the prevalence grouping of the county (p=0.0007) (Table 4.13).
All age groups except the 5-14 year olds had higher odds of reporting travel outside the
area when compared with the under 5 years age group. Similarly, patients in the more
rural counties had lower odds of reporting travel than those in the most urban counties
and patients from counties of lower prevalence had increased odds of travel outside the
area of residence when compared with patients who reside in counties of higher
prevalence.
Having a private well as the household drinking water source was reported by
31.3% of all cases. Drinking untreated water (not limited to the household water source)
was significantly associated with the urbanicity of the county of residence (p=0.0002)
Patients in the middle urbanicity groups (22-44% and 44-66% urban) had lower odds of
reporting drinking untreated water at 0.37 (95% CI: 0.15-0.95) and 0.25 (95% CI: 0.0940.69) respectively, when compared with cases who lived in the most urban counties. The
most rural counties were not significantly different in the percentage of patients who
reported drinking untreated water when compared to the reference group – the most
urban counties.
Hiking, camping, fishing or swimming in the 10 days prior to the onset of
symptoms was reported by 19% of the cases. Engaging in one of the four activities was
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Table 4.13: Associations between travel outside the area and age group, urbanicity
group and the prevalence group for a 16 county region in East Tennessee, 2003-2006
Odds Ratio
Exact p
Grouping
Group*
(95% Confidence
value
Variable
Interval)
5-14 years old
2.3 (0.84-6.2)
0.11
Age Group
15-29 years old
5.1 (2.1-12.0)
0.0001
30-49 years old
3.3 (1.4-7.4)
0.0048
50-64 years old
2.3 (1.0-6.9)
0.047
65 years and older
4.0 (1.4-10.8)
0.0095
0.36 (0.20-0.66)
0.0008
Urbanicity Group 44-66% urban
22-44% urban
0.25 (0.12-0.51)
<0.0001
0-22% urban
0.20 (0.059-0.69)
0.0053
5.5 (1.2-24.6)
0.025
Prevalence Group 0-6 cases/100,000
6-12 cases/100,000
5.6 (1.7-18.6)
0.0013
12-18 cases/100.000
1.9 (0.50-7.3)
0.54
*
Reference Groups:
Age – under 5 age group, Urbanicity – 66-88% urban, Prevalence – 18-24 cases
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significantly associated (p=0.0009) with the season of the year. Cases in the summer had
2.3 (95% CI: 1.1 - 4.6) times higher odds of reporting engaging in one of these activities
than those in the fall and 4.7 (95% CI: 1.9-11.6) times higher odds than those in the
winter. There was no significant difference (p=1.0) in the frequencies of reports of these
activities between summer and spring.
While handling raw meat was only reported by 21.2% of the cases, it was
significantly associated with sex (p=0.017) and age (p=0.0002). Women had 1.5 (95%
CI: 1.0-2.7) times higher odds of reporting handling raw meat than men. Patients in the
middle age groups (15-29, 30-49 and 50-64) had higher odds of reporting exposure to
raw meat compared to the under 5 age group (Table 4.12). There was no significant
difference in the odds of handling raw meat between the under 5 age group and the 5-14
and 65 and over age groups. Having a household member in daycare was also
significantly associated (p=0.013) with the age group of the patient. Patients in the 15-29
and 50-64 age groups had significantly lower odds of reporting a family member in
daycare than the under 5 age group. The other comparisons were not significant.

4.2.7 Prevalence Distribution
The mean crude prevalence of campylobacteriosis in the 16 county region during
the study period was 10.4 per 100,000 (95% CI: 9.5 - 11.4). The crude prevalence
estimate for all FoodNet sites in the US during the same period was 12.7 per 100,000
(95% CI: 12.4 - 13.0), while that of the entire state of Tennessee was 7.40 per 100,000
(95% CI: 6.7 - 8.1).
The county level age- and sex-standardized prevalences of campylobacteriosis are
presented in Figure 4.1. Grainger and Jefferson counties had the highest prevalences at
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Figure 4.1: Age- and sex-standardized prevalence of campylobacteriosis and 95% confidence intervals for a 16 county
region in East Tennessee, 2003-2006
86

22.9 and 21.8 cases per 100,000 population, respectively; while Hamblen and Roane
counties had the lowest at 3.8 and 4.4 cases per 100,000 population, respectively. Some
counties in the study area had prevalence values that were much higher than the national
average. Age- and sex-standardized prevalence estimates for each CCD are show in
Figure 4.2; no cases were reported in some CCDs (white) and the prevalence of
campylobacteriosis was the highest in the Philadelphia CCD of Loudon County and the
Washburn CCD of Grainger County at 67 and 57 cases per 100,000, respectively (dark
blue). The CCDs were grouped based on the urbanicity of the residents, in 10%
increments. The prevalence of campylobacteriosis in these groups ranges from 7.6 – 14.0
cases per 100,000, but none of the groups differed significantly and there was no trend in
the prevalence of campylobacteriosis.
The age- and sex-specific prevalence estimates of campylobacteriosis for the
entire study region are shown in Figure 4.3 for each age group. The highest reported
prevalence estimate was observed among male children under the age of 5 at 47.7 cases
per 100,000 (95% CI: 36.6 - 61.2), and the lowest was reported among females aged 65
and older at 5.95 cases per 100,000 (95% CI: 3.6 - 9.2). There was no statistically
significant (p>0.05) difference in the prevalence of campylobacteriosis between males
and females across all age groups.

4.2.8 Temporal Patterns
The mean annual prevalence of reported cases of campylobacteriosis in East
Tennessee gradually declined over the 4 year study period, while the prevalence in the
US and the state of Tennessee remained approximately the same (Figure 4.4). The
overall crude prevalence of campylobacteriosis was 13.39 cases per 100,000 population
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Figure 4.2: Age- and sex-standardized prevalence of campylobacteriosis for each census county division in a 16 county
region in East Tennessee, 2003-2006
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Figure 4.3: Age- and sex-specific prevalence of campylobacteriosis in a 16 county region in East Tennessee, 2003-2006.
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in 2003 in ET. This prevalence was not statistically different from the prevalence of
disease for the entire FoodNet area in the United States, of 12.60 cases per 100,000
(p=0.4759), but was significantly (p<0.0001) different from the prevalence of disease in
the state of Tennessee (7.81 per 100,000). By 2006 the prevalence of disease in ET had
decreased to 8.51 per 100,000. This was significantly lower (p=0.0002) than the
prevalence in the US (12.71 per 100,000) but not significantly (p=0.227) different from
that of the state of Tennessee (7.40 per 100,000). The annual prevalence of
campylobacteriosis in ET in 2003 was significantly different from the prevalence in 2005
(p=0.005) and 2006 (p=0.0008). The critical p-value of Simes correction for multiple
comparisons was 0.0167. There was no significant difference in the prevalence of
disease among the other years of the study.
The monthly prevalence of campylobacteriosis and 3-month moving average are
shown in Figure 4.5. The linear regression line shows an overall decreasing temporal
trend in the prevalence of disease in the region. Over the course of the study, the mean
monthly prevalence had a decreasing trend at a rate of 0.0085 cases (per 100,000) per
month. A consistent peak in the reported prevalence of campylobacteriosis occurred in
the summer months of each year. In November of 2004 there appeared to be an offseasonal peak in the prevalence of campylobacteriosis, but this peak was not significantly
higher than the prevalence during the other winters of the study period (Figure 4.6). The
average summer prevalence (3.9/100,000) was significantly higher (p=0.0003) than that
in the fall (2.5/100,000), winter (2.2/100,000, p<0.0001) and spring (1.9/100,000,
p<0.0001). The summer of 2003 had highest seasonal prevalence at 5.6 cases per
100,000 (CI: 4.2-7.2), while the spring of 2004 had the lowest at 1.3 cases per 100,000
91
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(95% CI: 0.73- 2.2) (Figure 4.6). The only significant difference in the monthly
prevalences was identified between the summer months (June, and July) and the month of
April (Figure 4.7). July had the highest average reported prevalence of 1.6 cases per
100,000 (95% CI, 1.3-2.1) followed by June (1.1 cases per 100,000; 95% CI, 0.86-1.5)
and August (1.1 cases per 100,000; 95% CI, 0.80-1.5). April had the lowest average
reported prevalence at 0.57 cases per 100,000 (95% CI, 0.37-0.85).
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5.0 Discussion
The goal of this study was to perform a descriptive epidemiologic analysis of the
cases of human campylobacteriosis reported in East Tennessee from January 2003 to
December 2006. Information resulting from the study may be used by health
departments in East Tennessee to help enhance their strategies for disease control and
prevention. Generally, most of the epidemiologic characteristics of the
campylobacteriosis cases observed in this study were similar to those in other studies
conducted in the United States and around the world. For instance, the highest
prevalence occurred in young children under the age of 5 and during the summer months.
These are patterns typical of campylobacteriosis in the developed world.
The error rate observed in the data used in this study varied greatly depending on
the year, the type of error (inaccuracy or missing information) and the health department
(KCHD or ETRHD). Missing information or omissions in the computerized dataset,
when information was present on the paper case report form, were classified as missing
information errors since it can not be determined if the data was missing due to an
oversight, a computer malfunction or purposeful omission. The highest proportions of
errors, from both health departments, were observed in 2004. One reason for these high
error rates could be a change in the database structure that occurred when a new data
storage software application was adopted in 2004. When this change occurred,
differences in the field names in between the two different databases may have caused
data to be deleted from some entries. It is also possible that data could have shifted
between entries, for example, the address for one patient was assigned to another patient
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numerically ahead of that entry. Since this change in database structure occurred during
2004, only cases reported prior to the change were affected. These issues suggest that
there needs to be safeguards put in place to take care of potential data integrity issues
during system upgrades and improvements in data structure.
Another problem observed in the data entry was that many patients were entered
into the database as white or Caucasian when the race or ethnicity box on the case report
form was left unchecked. These patients were entered into the systems as “race = white”
or “ethnicity = non-Hispanic”, when they should have been entered in as “race =
unknown” or “ethnicity = unknown”. This resulted in the high inaccuracy error rate
observed in the race (10/79, 13%) and ethnicity (30/79, 38%) variables. The “travel”
variable had a high percentage of missing information errors (8/79, 10%). The paper case
report form indicated the patient had reported travel and this was not in the computer
database. Some of these errors were caused by the fact that the variable “travel” was
added to the electronic database partway through the study. It was introduced into the
computer database during 2005, but due to the way the data is stored, all cases prior to
the introduction date still had the travel variable present in their database entry, but it was
blank.
The inaccuracy error rates observed in this study were similar to that reported for
data quality in electronic medical databases[266, 267]. A study of a voluntary
participation database of low birthweight infants in Vermont, found inaccuracy error rates
between 1.3 - 8.8%[266]. That study analyzed ten variables for disagreement between
the medical record and the computerized database. Another study conducted in
Pennsylvania analyzed the results of multiple published studies that reported the accuracy
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of computer-based patient records (CPRs). The inaccuracy error rate of the CPRs ranged
from 0 to 64%[267], but most of the studies analyzed reported an inaccuracy error rate
between 3-7%. In this study the highest inaccuracy rate observed was 6.2% in the 2004
Knox County dataset, and the overall inaccuracy rate for all datasets was 3%. As with
the missing data errors, the maximum and average percentages of inaccurate entries in the
campylobacteriosis database in this study were within the range of inaccuracy errors of
CPRs in the literature[267]. It was important for all the variables in the datasets used in
this study to have complete and accurate information since they were used to create sub
populations, to identify groups with a higher prevalence of campylobacteriosis.
Missing data error rates observed in this study were low (3.4%). When missing
data is expanded to included unknowns the percentage ranges from 0-52% (Table 4.2),
these are similar to other descriptive studies of gastrointestinal illness using surveillance
data[268, 269]. In published reports the percentage values that are unspecified or missing
has a wide range. A Canadian study of Salmonella serotype typhimurium reported 099.8%[268] missing or unspecified values depending on the variable. In that study,
variables that had all data present were “Episode date” and “Disease”, while the variables
with the highest percentage of missing data were “Hospitalization” (71.5%) and “Risk
factor” (99.8%). Another Canadian study of cryptosporidiosis reported a similar range of
0-89.7%[269] of cases with missing or unspecified values. In both Canadian studies the
percentage of missing values was lower among the variables that were mandatory for
reporting, especially demographic variables. Of the mandatory variables in the Canadian
studies, “Risk Setting” had the highest percentage of missing values (49.6%). In the
present study, the highest percentages of unknowns were observed for the variables
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“Where was treatment sought” (52%) and Serotype (49%). These variables were not
required for reporting, while demographic variables such as age, sex, and race were, and
as such had low (0-5%) percentages of unknowns.
The median age of patients in this study (26 years) was within the range of
median ages reported by two Norwegian studies (22 and 29 years)[270, 271], but lower
than median age of a 2000 case-control study in Quebec (median: 31 years, range: 11days
– 91 years)[197] and a 1999 United States FoodNet case-control study (median: 34,
range: <1-96)[198]. In the current study, the median age was significantly lower in the
more rural counties. The study area (ET), on average, has more of the population
classified as rural compared to the other FoodNet sites and this difference and the lower
median age observed in the rural areas may have influenced the lower median age
observed in this study compared to other US studies.
The percentage of cases under the age of 1 (9%) was much higher in ET than
other published studies that reported 1.9% in New Zealand[19], and 3.5-4.0% in US[239]
of cases under 1 year old. In this study, the percentage of patients under 5 years old (24
%) was also higher compared to those of other studies: 16.9% in Norway[270], 13.413.8% in the US[239], 12.0% in New Zealand[19], and 11.5% in the United
Kingdom[203]. A Polish study that analyzed the test results of all stool samples that
were submitted for enteric disease isolation, found that 59% of the campylobacteriosis
isolates were obtained from children under 2 years old[272]. That is much higher than
the percentage observed in this study and may be due to differences in exposures or
health care practices. In countries where there is universal heath care, more adults may
seek medical care for their symptoms than in counties without universal health care
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which can affect the percentage of children in the study. It is possible that the age
differential observed in the US (more children seek medical care compared to adults) is
more pronounced in Poland, or that children are exposed at a much higher rate in Poland
so adult have some immunity and do not seek medical care.
The median age of patients from the most rural counties in ET was lower than that
of the rest of the counties in this study (Table 4.3). This is similar to the findings of a
previous study that reported that more children were reported in the rural areas compared
to the urban ones and the odds of infection increased in the more rural areas, especially
for young children[245]. The lower median age in the rural counties could be due to the
fact that young children in the more rural counties may be exposed to Campylobacter at a
higher frequency than children in the more urban counties due to higher risk of animal
exposure. Moreover, the predominance of children in the rural areas of ET could be
partially explained by the large percentage children in this study (>50% of children under
1 year old) who drink privately owned well water that may not be appropriately
disinfected.
On average patients in ET waited 3 to 4 days to seek medical care after the onset
of their symptoms, 52% waited 3 days or less. This delay may reduce the effectiveness
of antibiotic treatment. A meta-analysis of studies of the treatment of campylobacteriosis
found that patients who waited 3 days or more to seek care reported the duration of
diarrhea to be twice as long as patients who sought care less than 3 days after the onset of
symptoms[86]. That study also reported that in 50% of the studies, the patients waited
less than 3 days, while in the other 50% of the studies, the patients waited an average of
6.5 days to seek care. The reason for the longer delay in seeking care observed in
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patients in ET may be due to the fact that patients in the US normally have to wait several
days before they can be seen in a private physician’s office[273]. One survey of health
care practices found that 50% of adults in the US had to wait for 2 or more days to see a
physician[273]. Generally, most patients will wait for symptoms to warrant medical care
(either in severity or duration), and then many will have to wait several additional days
for an appointment to be seen by a physician. These delays may prolong the duration of
symptoms.
More patients in the present study (50%) visited an emergency room for their
illness compared with patients in the FoodNet case-control study (37%)[198]. It is
possible that the lower percentage of patients seen in the emergency room in the 7 states
involved in the FoodNet study could be due differences in the physician to patient ratio or
differences in the proportion of patients with health insurance between ET and the
FoodNet sites. The decision to seek medical care for their symptoms may be based on
the patient’s socioeconomic status as well. A US study of adult healthcare practices
found that 57% of adults with “below average income” would choose not to visit a
physician when ill due to the cost compared to only 12% of adults with “above average
income”[274]. In Tennessee, there are programs for children to obtain health insurance
through TennCare (the state healthcare provider) so more children may be seen by private
practice physicians, since they have insurance, while those over 18 who do not have
insurance may go to the emergency room to seek medical care. The percentage of
patients seen in a physician’s office, in this study, was higher for patients under 18 years
of age (55%) than those over 18 (45%) but this difference was not statistically significant.
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Most (99.5%) of the cases of campylobacteriosis in ET were diagnosed from a
stool sample and the rest (0.5%) were identified from a blood sample; this percentage is
identical to that observed in the FoodNet case-control study in 1998-1999[198]. The
descriptive FoodNet study from 1996-1999 found similar results, 99% of samples were
from stool and 1% were from blood[239]. Approximately half of the Campylobacter
isolates in the present study were sent to the state laboratory for speciation. The
percentages of each Campylobacter species observed in this study (C. jejuni: 98.6%, C.
coli: 0.9%, dual infection: 0.4%) are similar to those observed in 7 states of the United
States in 1998-1999. That FoodNet case-control study of 1316 patients, reported 95% C.
jejuni, 4% C. coli, 1% C. lari, and 1 case of C. mucosalis[198]. In a Norwegian study,
92% of the 212 cases were infected with C. jejuni while the remaining 8% were infected
with C. coli[271]. A study of 285 cases in France found 81.7% infected with C. jejuni,
15.3% with C. coli, 1.3% with C. fetus, and 1.7% with C. lari[275]. The lower isolation
rate of C. coli (commonly identified in pigs) observed in the current study may be due to
either fewer isolates being sent to the laboratory for species determination, or a lower
prevalence of the bacteria in the region. The lack of C. lari and C. upsaliensis (reservoirs
unknown) isolation in ET may be due to its low prevalence in the region or the growth
inhibition of C. upsaliensis by the antibiotics used in the standard stool culture
media[41].
Diarrhea is considered a hallmark symptom of campylobacteriosis, 97.5% of
patients in ET who provided clinical information reported experiencing diarrhea. This is
similar to other descriptive studies. A smaller study conducted in Denver, CO in 1979
reported 100% [117], a report from England and Wales observed 96% [276], and a
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French study reported 96.5%[275] of patients experienced diarrhea. On the contrary,
volunteers who were experimentally infected with C. jejuni all had positive stool cultures,
indicating infection, but only 46% experienced diarrhea[76].
Just over a third of the patients in this study reported bloody diarrhea. This may
be under-reported since some patients may not have examined their stool closely and may
have missed seeing blood. This percentage is lower than other reports from the United
States but similar to other worldwide reports and the results of experimental infections.
In the FoodNet case-control study, 45% of patients reported bloody diarrhea[198], while
a 1978 US study reported 42%[117]. Human experimental infections, conducted in
Maryland, found that of volunteers with positive stool cultures, 36% experienced bloody
diarrhea[76]. Worldwide, bloody diarrhea was reported by 35.2% of patients in New
Zealand [199], 28% in England and Wales[276], 45% in Iran[277], 22% in Yemen[278],
10% in Bangladesh[279] and 15% in Thailand[280]. The percentage of patients who
experience bloody diarrhea may depend on the virulence of the strain or species of
Campylobacter and the immune status of the patient[281]. If the bacteria are able to
damage the intestinal epithelial cells sufficiently by invasion or toxins, bleeding may
occur.
The majority of patients in ET also reported fever (62.5%), and cramps (56.2%);
only 37.5% of patients reported experiencing both. These symptoms were observed at a
lower rate than the FoodNet case-control study in which over 80% of patients reported
fever and cramps[198] and a smaller 1978 study of 35 patients where 96.6% experienced
“abdominal pain” and 91% experienced fever[117]. Among studies conducted in other
industrialized countries, these symptoms were also reported more frequently than the
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findings of the current study[19, 276]. In a study conducted in Yemen, a lower
percentage (21%) of patients reported fever but “abdominal cramps” were reported by a
higher percentage (86.6%) when compared to patients in ET. Since symptoms in this
study were self reported, differences in interviewer phrasing, interpretation of the
responses or degree of emphasis of the questions could have influenced the response of
the patient. One reason for the lower percentage of patients reporting cramps, in this
study, may be the large proportion of children under 5 in the study dataset. These
children may be unable to understand what the symptom is or be able to communicate the
source of their discomfort to their parents who were interviewed for this information.
Associations between clinical symptoms in the present study were examined to
determine if symptoms were commonly reported in combination, which may indicate
similar strains of Campylobacter spp. A quarter of the patients reported nausea and
vomiting together; this is logical since nausea is the conscious recognition of the
subconscious excitation of the medulla associated with the vomiting center[179]. Also
associated were the reporting of nausea with cramps, headache with fatigue and headache
with muscle aches. None of these associations of symptoms formed temporal or spatial
clusters that would indicate that the cases may have been associated or from the same
strain.
Interviewer phrasing may have also influenced the percentage of patients
reporting chills. In 2006, the symptom “chills” was added to the new campylobacteriosis
case report form as a possible symptom in the form of a check box. After the new case
report form was implemented, the interviewer specifically mentions chills, while prior to
this time chills was only reported if the patient initiated the response when questioned for
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“other”. After this change in the case report form, the percentage of patients who
reported chills dramatically increased. During the first 3 years of the study (2003-2005),
1.0% to 6.4% of patients reported experiencing chills, however in 2006 this percentage
jumped to 22.4%. This increase was not likely due a true increase in percentage of
patients experiencing chills, but more likely due to its inclusion on the symptom list on
the case report form, about which patients are questioned.
There was an association between some symptoms of campylobacteriosis and the
age of the patient, in this study. These associations were investigated to see if there was a
pattern of symptoms being reported by patients in different age groups, since previous
studies reported an association between age and bloody stool. Patients in the youngest
age group (under 5) were more likely to report bloody diarrhea than those in the older age
groups (Table 4.7). A similar observation was made in France where 54.8% of children
15 and under reported bloody diarrhea while only 35.1% of patients over the age of 15
reported it [275]. A study in Thailand also reported a similar result; 30% of children
under 5 years old experienced bloody stool while only 15% of all ages experienced
it[280, 282]. It has been hypothesized that this age related difference in the occurrence of
bloody diarrhea, could be due to the infection being the first exposure to Campylobacter
among young children which cause bloody diarrhea[283].
While a statistical association between age group and non-visible symptoms of
campylobacteriosis exists, it may have no clinical relevance. These include the nonvisible symptoms of nausea, cramps, muscle aches, headache and fatigue where is no
physical evidence of the symptom. Since the parents may not recognize these symptoms
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in their young child if the child could not communicate these symptoms to their parent,
one or more of these symptoms may have been present but not reported.
The duration of symptoms varied widely among the patients in ET (range: 1 day180 days). The patient that reported 180 days also reported experiencing gastrointestinal
symptoms for several months before seeking medical care and may have attributed
previous symptoms to their campylobacteriosis diagnosis. The median duration of
disease (7 days) experienced by patients in this study is similar to reports from the US
and other industrialized countries. In the FoodNet case-control study of 1999 the median
duration was 6 days, (range: 1-31 days)[198]. The CDC reports that most cases recover
completely in 2-5 days, but sometimes recovery can take up to 10 days[284]. A smaller
study in Colorado reported that 80% of patients experienced a duration of illness of 1
week or less[117].

A 1982 study in West Germany found the average duration of

diarrhea to be between 2 and 7 days[285]. The median duration of disease was also 7
days, but with a much shorter range(1-16 days) in New Zealand[199], while the range
was much longer (0-701 days) in England and Wales where an average of 10.7 days of
illness per patient was reported[276]. Reducing the duration of disease can have
substantial effect on the cost of campylobacteriosis by reducing hospitalizations costs and
lost wages.
When classified by the severity of disease index, almost half (48%) of the patients
in this study experienced mild disease and less than 10% experienced severe disease.
The scale was used to provide a method to classify patients according to their severity of
disease and possibly identify population groups who experience more severe disease,
however none were identified. One disadvantage of the severity of disease scale is that it
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is heavily dependent on symptoms of disease, many of which are not visibly identifiable
in young children such as: muscle aches, fatigue or cramps. The highest severity score
for a child under 5 years old was 13. That child was 4 years old and may have been able
to communicate more of the signs of illness to their parents; that child reported fatigue,
cramps ad nausea. If the children in the youngest age group (under 5) are removed from
the mean calculation, the mean severity score increases from 7.6 to 8.1±3. This increase
may not necessarily indicate that adults experience more severe disease than children, but
may be due to the fact that they are able to report symptoms themselves. A better
severity of disease scale could have two possible values, one for adults and children over
5, and a different value for children under 5.
The following recommendation for the treatment of campylobacteriosis is found
at the CDC website:
“Almost all persons infected with Campylobacter recover without any
specific treatment. Patients should drink extra fluids as long as the
diarrhea lasts. In more severe cases, antibiotics such as erythromycin or a
fluoroquinolone can be used, and can shorten the duration of symptoms if
given early in the illness. Your doctor will decide whether antibiotics are
necessary.”[284]
The majority (84%) of patients in this study received at least one antibiotic. The most
common antibiotics prescribed were fluoroquinolones and macrolides which are in line
with the CDC’s recommendations. No information on antibiotic sensitivity testing of the
Campylobacter isolates was collected in this study, but sensitivity testing may become
more common since antibiotic resistant Campylobacter are becoming more
prevalent[286].
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The percentage of isolates that are fluoroquinolone resistant is increasing
worldwide, especially in developing countries[82]. In my travels in developing countries,
I noticed it was common practice to take a single antibiotic pill, instead of a full course of
several days of treatment, to treat minor infections and other illnesses such as a cold.
Such practices may play a role in the higher Campylobacter resistance rates in these
countries. This is also important since many adults in developing countries can be
asymptomatically infected with Campylobacter. Due to the high level of Campylobacter
resistance to fluoroquinolones outside the United States (84% in Thailand[287] and 72%
in Spain[140]), doctors should consider travel history and exercise caution when
prescribing fluoroquinolones to those who have traveled internationally[146]. It is
important since some studies have shown that treating fluoroquinolone-resistant
campylobacteriosis with a fluoroquinolone causes more severe disease[144].
The youngest age group (under 5) had the lowest percentage of patients who
reported receiving an antibiotic (77%) while 100% of patients in the 65 and over age
group received at least one antibiotic. The higher percentage of patients receiving an
antibiotic in the oldest age group may be due to concerns of the physician that older
patients may have other medical conditions that could increase the risk of complications
if the infection is not treated aggressively[288]. The lower frequency of antibiotic
treatment among young children may be due to fears of antibiotic complications[135]. In
young children there is an increased risk of hemolytic uremic syndrome (HUS) if infected
with E. coli O157:H7 which is the most common cause of bloody diarrhea in
children[135]. Due to the risk of complications, antibiotics should not be prescribed to
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children before the etiologic agent can be confirmed and a confirmatory diagnosis
made[48].
Similar percentages of infants under age 1 were treated with antibiotics in ET
(72%) and other FoodNet sites (72%) [14]; however the percentage for children under
age 1 year old and 5 years (77%) were much higher than other countries. A Swedish
case-control study of children under 6 reported that only 13.4% were prescribed an
antibiotic[204]. This difference could be due to differences in the specific policy and
treatment guidelines of the national public health agency of each country. In the US, the
CDC recommends that an antibiotic could shorten duration and a doctor will decide if
one is necessary. While the Swedish Society for Communicable Disease Prevention and
Control and The Swedish Institute for Infectious Disease Control both state that the
infection generally clears up on its own with oral rehydration and antibiotics are only
given in rare cases[289, 290]. The emphasis of the Swedish recommendations is against
the empiric treatment with antibiotics and this may be the reason why fewer children
received them.
On average, 23% of the campylobacteriosis patients in this study were
hospitalized each year during 2003-2006. This is higher than that reported in the
descriptive FoodNet study of 12,707 patients from 1996 to 1999 (10%)[239], the
FoodNet case-control study of 1316 patients in 1998-1999 (12%)[198] and a 2001 report
of 286 patients in the Denver metropolitan area (9.8%)[291]. The percentage of
hospitalizations in ET is also much higher than in other countries: reported percentages of
hospitalizations are 3% in Ontario, Canada[292], 4.9 % in New Zealand[19], 10.2% in
England and Wales[276], and 10.8% in Denmark[293]. In the present study, some (30%)
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patients spent 1 day or less in the hospital, if these patients are removed, the proportion of
patients hospitalized (LOS >1, 16.5%) was also higher than expected. Of the states
participating in the descriptive FoodNet study, Georgia had the highest percentage of
cases hospitalized at 15.2%[239]. Georgia borders part of Tennessee to the South and the
percentage observed there is closer to that observed in ET. The higher than expected
percentage of hospitalizations among the older patients (65 and up) may have led to a
higher than expected overall percentage hospitalizations.
The observed high hospitalization percentage (60%) among the 65 and older age
group of patients in this study was much higher than the overall percentage (23%) for all
ages. This difference could be due to complications from other health conditions that are
more common in older patients. The hospitalization proportion observed in the oldest
patients (65 and up: 60%, 60 and up: 56.3%) was also much higher than that reported in
the 1996-1999 FoodNet study (26.8% of patients 60 and older)[239] and a New Zealand
study (9.6% of patients 60 and older)[19]. The lower percentage of hospitalization of
older patients observed in New Zealand may be due to differences between the health
care systems of the two countries. In New Zealand, on average, patients are seen by a
doctor sooner, may be treated sooner, may not develop as severe of disease and therefore
may not need to be hospitalized. In a study of worldwide healthcare practices, 58% of
adults in New Zealand were seen by a doctor the same day and 81% were seen by the
next day compared to the US where only 30% are seen on the same day and 47% by the
next day[273].
The under 5 age group had the lowest percentage of patients hospitalized (11.5%).
This may be due to the fact that parents take their younger children to the doctor at the
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first sign of illness and the child is then treated early on in the course of disease thus
reducing the need for hospitalization. One theory for the higher hospitalization
percentage in the 5-14 age group (27.3%) was that older children may wait longer to seek
medical care resulting in a higher hospitalization percentages, however this was not
validated in this study as the median delay in seeking care was 3 days for both age
groups.
Although, patients in the present study were hospitalized more often than the rest
of the country and other parts of the world, the length of stay (LOS) was on average
shorter for patients in this study (median: 2 days, range: <1 to 11 days). In the FoodNet
study using data collected from 1996-1999 the mean LOS was 4.6 days and 8% of the
cases that were hospitalized spent more than one week in the hospital[239]. Only 4 of the
101 (4%) hospitalized patients in ET remained in the hospital for 7 days or more. A
Denver 2001 report also observed that 4% of patients had a LOS greater than 7
days[291]. The mean LOS was longer (3.9 days) in England and Wales[276]. It is
possible that the patients who were hospitalized in this study were less severely affected
as patients who were hospitalized in other states and countries and therefore did not
require as long of stay in the hospital. Patients in this study who were hospitalized had a
higher severity score than those who were not.
The highest percentage of hospitalizations (28.4%) occurred in the summer, and
the fewest in the winter (19.8%). This difference may be due to a greater seasonal
potential for exposure due to differences in behaviors, such as more outdoor activities and
more travel. During the summer, due to the hot weather, more recreational water
activities occur, in rivers and lakes, such as fishing, boating, and swimming. Also more
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outdoor barbecues occur during the warmer months; during these events there is a higher
risk of consumption of undercooked meat and cross contamination of food which could
lead to a larger inoculum of the bacteria from the undercooked food. The seasonal
differences in the hospitalization percentages observed in this study are unlike those
described in New Zealand where the percentage of cases hospitalized remained almost
constant between 4.7 and 5.0 percent in each season[19]. Although the seasons are
reversed in New Zealand and the climate of the entire country is not exactly the same as
ET, there are still large temperature differences between the seasons, similar to the
temperature changes observed in ET.
During the 4 year study period, only 1 (0.3%) patient died. A 4 year FoodNet
study of 5 sites reported that 11 patients died as a result of their illness[239]. The average
annual campylobacteriosis specific mortality risk (number of deaths due to
campylobacteriosis/total study population) was 0.096 deaths per 100,000 in ET and 0.074
per 100,000 in the FoodNet sites. While the campylobacteriosis specific mortality risk
was higher in ET, this difference was not statistically significant, since both estimates
have wide confidence intervals due to the low number of total deaths.
Contact with animals in the 10 days prior to the onset of symptoms was the most
commonly reported risk factor in this study. This is an important health concern since
Campylobacter is a zoonotic agent that can infect both animals and humans, and animals
can be asymptomatically infected. One report warns that exposure to a dog with diarrhea
triples a person’s risk for campylobacteriosis[294]. Due to the increase in the number of
stools for a dog with diarrhea, there may be a higher risk of fecal exposure, but studies
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have shown that dogs with and without diarrhea are equally likely to carry
Campylobacter[35, 295, 296].
Dogs (74%) and cats (33%) were the two most commonly reported animals that
patients were exposed to in this study. Depending on the location and clinical conditions
of the animals sampled and the Campylobacter species isolated, infection rates have been
reported at 27.9%[297], 15-26% [298], and 51.1-87%[299] in dogs and 16.8% [300] and
24% [36] in cats. Cats have been found to be infected with C. upsaliensis more frequently
than C. jejuni or C. coli; however this species is not frequently identified in humans. The
lack of identification in humans could be due to growth inhibition of C. upsaliensis by the
antibiotics used in the standard stool culture median used in the isolation of
Campylobacter spp. In spite of this, cats still remain an important health concern of
zoonotic campylobacteriosis. Almost 10% of patients reporting animal exposure came in
contact with live chickens. Poultry are an important reservoir of Campylobacter. At a
live poultry market in New York, 83% of the chickens were positive for
Campylobacter[301] and 27% of broilers were positive at a farm in England[302]. Daily
contact with poultry had borderline significance as a risk factor for campylobacteriosis in
a case-control study in Denmark (OR:2.11, 95% CI: 0.99-4.49), but daily contact with a
cat with diarrhea (OR:3.77, 95% CI: 1.03-13.83) or a cow (OR:3.09, 95% CI: 1.09-8.74)
were found to be significantly associated with disease[13].
Children in this study under 5 years old were more than 3 times more likely than
those over 50 to report animal exposure; this is most likely due to difference in behaviors
of these age groups. One reason may be that children are more likely to have a family
pet, visit friends with pets or go on a school trip that could put than in contact with
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animals compared to older adults. Also children are less likely to wash their hands after
handling animals, while older adults most likely will. One case-control of children in
Sweden found the odds ratio for reporting dog exposure to be higher for children under 2
years (9.1, 95% CI:3.7-27.0) compared to the odds ratio for children aged 2-6 (2.4, 95%
CI:1.1-5.1)[204]. While the present study did not include controls, the pattern observed
in the Swedish study is similar to the pattern observed in this study, that children had the
highest animal exposure.
Of all the animal exposures recorded in this study, it was not noted if the contact
occurred in a work or recreational environment. The type of contact could change the
amount of exposure that occurs. Another study defined contact with an animal as
“handling or touching the animal or its excrements”[202]. No definition was used in this
study, so it is possible that some patients, who reported contact, may not have been
classified as exposed if the previous definition is used. A more thorough definition might
include a quantification of the amount, duration, and type of exposure to the animal (in
the same room as an animal, just hand contact, had animal on lap, facial contact with the
animal, contact with animal excrement, if the animal sleeps on the bed). Since the
animals in question were not tested for campylobacteriosis as well, it can not be assumed
that the human infection was caused by to the animal exposure.
Travel outside the state or country was the next most commonly reported risk
factor (21.6%). The percentage of patients in this study who reported international travel
(11.3%) is similar to that of the FoodNet case-control study (13%). More patients in ET
traveled to Central and South America (23%) compared to patients in the FoodNet study
(10%) but fewer traveled to Europe. The difference in destination between the two
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studies may be due to type of travel (business, pleasure or altruistic) or differences in the
socioeconomic class of the populations. Several cases in ET noted that they contracted
campylobacteriosis while on church mission trips, some of which were to Central and
South American countries. Altruistic trips, such as church mission trips, are often made
to the more rural parts of developing countries, where the risk of exposure is greater.
These trips may be an important source of exposure and a factor in the prevalence of
campylobacteriosis in the region and in the rest of the US.
A French case-control study found that 5.6% of the cases and only 2.4% of the
controls reported international travel in the 8 days prior to the onset of symptoms, which
was a borderline significant a risk factor (OR=2.5, 95% CI: 0.9-6.4)[275]. None of the
patients in that study visited Central or South America. The percentage of international
travel observed in that study is lower than that observed in the present study. This may
be due to the destinations of the patients in the French study being less rural compared to
those in this study. In Denmark, travel was identified as a risk factor in a 1996-1997
case-control study. In that study, travel was reported by 18.4% of the cases and only
9.4% of the controls[13]. The percentage of patients reporting international travel is
much higher in Denmark where most cases had a history of travel to “Southern Europe,
the Middle East or Asia.” Since that study did not differentiate the percentages of
patients traveling to each location, it can not be compared to the locations in the present
study. The present study is also very different from a Norwegian study which reported
that 53% of 12,327 cases that occurred between 1995 and 2001 were acquired abroad.
The differences in travel patterns observed among the various age groups (Table
4.13) may be related to behavioral patterns of the age groups. Many adolescents and
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young adults in the 15-29 age group report international travel since many college
students spend semesters abroad and members of this age group may be able to travel
more due to more disposable income and many do not have children yet. Members of the
65 and over age group are past retirement age and therefore may have more time for
travel, however the most of the patients in this study traveled locally, within the United
States.
The odds of reporting any travel were 2.8 - 5.0 times higher for patients in the
urban counties than those in the more rural counties. This may be due to differences in
socioeconomic class; people in the more urban counties may be able to afford more
travel. This is especially true for international travel, none of the patients in the least
urban counties traveled internationally, while 59.6% of patients in the most urban did. It
is possible that more patients in the urban counties had jobs that required international
travel, or a higher income compared to patients in rural counties. There was also an
association between the prevalence group of a county and travel; patients from counties
with a lower prevalence were more likely to report travel. This result could be influenced
by the urbanicity of the counties since the counties in the highest prevalence group were
also some of the most rural counties.
Handling raw meat or poultry was reported by 21.6% of the cases in East
Tennessee. This is lower than observed in the FoodNet case-control study where 48% of
patients reported preparing raw chicken and 27% of patients reported touching raw
chicken[198]. It is possible that some of the difference in the percentages between this
study and the FoodNet study observed is due to differences in the phrases “prepare” and
“handle”. There was a large difference in the FoodNet study, with more patients
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reporting preparing than handling. It is possible that in this study someone may have
reported preparing raw chicken, but not handling it which could explain the lower
percentage observed for raw meat exposure. No information was provided in the
FoodNet report on exposure to meat other than chicken. The percentage of patients who
reported handling raw meat in East Tennessee is similar to that observed in France where
19.4% of patients prepared meat or poultry[275]. A case-control study in Norway found
preparing raw poultry to be a significant risk factor for disease, 20% of the cases reported
it, while only 2% of the controls did (OR: 9.55, 95% CI: 2.09-43.69)[202]. Due to the
high level of Campylobacter contamination that has been reported in some retail poultry
products, (81% of 525 chickens sampled in a Consumer Reports study[71]), care should
be taken to avoid direct exposure from raw meat, through thorough hand washing. A
Swedish case-control study observed that 16% of campylobacteriosis cases did not clean
their hands during food preparation compared to only 10% of controls[208]. Another
case-control study in Seattle, WA found that cases were less thorough than controls in
cleaning meat cutting surfaces or using separate cutting surfaces[303]. Cutting surfaces
should be thoroughly cleaned and separate surfaces should used for meat and produce.
Meat should also stored on the lowest shelf in a sealed container to avoid cross
contamination of other foods.
Reporting the risk factor “handling raw meat or poultry” was significantly
associated with the sex of the patients with females having 1.5 times higher odds of
reporting handling raw meat or poultry, when compared with males. This difference may
be due to cultural and behavioral differences between the sexes; women are more likely
to prepare meals at home. There was also an association between handling raw meat and
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age; with members of the 30-49 age group reporting the highest percentage of raw meat
handling (37.1%). Members of this age group had 12 times higher odds of reporting
handling raw meat or poultry when compared to patients in the under 5 age group (4.4%).
This difference could be due to behavioral factors since young children (under 5 years)
rarely help in the preparation of the meal and when they do, it usually does not involve
handling raw meat.
Swimming in water from natural sources has been shown to be associated with
the acquisition of campylobacteriosis[207], and other recreational water use such as
fishing or boating may pose a similar risk. Recreational water has also been associated
with an outbreak of waterborne gastrointestinal illness caused by Cryptosporidium in ET.
That outbreak occurred at a “splash pad” (an interactive fountain where children play in
the water that comes up as jets from the ground) during the summer of 2006[304].
Recreational water exposure was included by the health department on the
campylobacteriosis case report form under the risk factor variable “hike, camp, swim or
fish”. For this risk factor there was no distinction made between the type of water or
which of 4 activities took place or if water was ingested. In ET 19% of patients reported
at least one of the 4 activities in the 10 days prior to the onset of symptoms. This risk
factor was found to be associated with the season in this study. During summer and
spring 26.2% and 25.4% of patients, respectively, reported at least one of the 4 activities
compared to only 13.5% in the fall and 7.1% in the winter. These differences are likely
due to the climate of the area, very hot summers and cool winters, so participation in
these activities is more likely to occur in the warmer months.
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Due to the potential for fecal contamination, drinking untreated water is
considered a high risk behavior for exposure to Campylobacter[65, 67]. In East
Tennessee 10% of cases reported drinking untreated water from a stream, spring or other
untreated source in the 10 days prior to the onset of symptoms. In the FoodNet casecontrol study, drinking untreated water from a lake, river or stream was identified as a
risk factor in the univariate analysis; 4% of cases had engaged in this behavior compared
to just 2% of controls (OR: 2.9, 95% CI: 1.6-5.3)[198]. Both of these percentages are
much lower than the percentage of patients who drank untreated water in this study. The
percentage of patients who drank untreated water may be higher in ET than other US
sites because this type of water source and the practice of drinking untreated water may
be more common in the rural areas of ET than the population of the FoodNet study that is
more urban, on average. Patients who reported drinking untreated water were also likely
to report hiking, camping, fishing or swimming, with 7% of all patients reporting both
(OR: 13.5, 95% CI: 6.5-28.0). The wording on the case report form changed in 2006
from “Drink from a spring, stream or lake?” to “Did the patient drink untreated water?”
This change could have resulted in a higher or lower percentage of patients reporting this
risk factor so drinking untreated water cannot be analyzed across the years of the study.
Drinking well water has been identified as a risk factor for infection in casecontrol studies involving all ages in Finland[207] in children in Sweden[204], and in
infants in the US[14]. In ET, 31.3% of patients reported that their household drinking
water source was a private well and 3% reported it was a spring. Both of these sources
can become contaminated if not properly protected. Information was not collected on the
specific characteristics of each well or spring in this study; some patients noted that the
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well had been tested and treated, while others stated they had never treated their well. No
standardized data collection was performed regarding the timing or type of well testing or
treatment. Drinking well water was especially common in young children, 40.2% of
children under age 5 and 51.6% of children under age 1 had a well as their drinking water
source. These percentages are much higher (p=0.0012) than those observed in the infant
(<1 year of age) FoodNet case-control study where only 22% of cases and 8% of controls
used well water[14]. The higher observed percentage of well water reported in this study
may be due to an increased number of patients in the study from rural areas when
compared to the average of the FoodNet sites. Adults in the rural areas with household
well water may have developed immunity from past drinking water exposure and are
therefore a lower proportion of the rural adults may develop campylobacteriosis
symptoms. Immunity amongst the rural adults could also explain why there is a high
percentage of young children in the rural areas who drank well water. The Swedish casecontrol study of children also reported a difference in the percentage of cases on well
water based on age, 34% of children under 2 lived in a home with a well compared with
26% of children aged 2-6 years old[204]. While the percentages are still lower than those
was observed in this study, the same age pattern was reported. Not every well can be
considered the cause of the Campylobacter infection, however periodic monitoring and
appropriate treatment of wells is important in reducing the prevalence of
campylobacteriosis.
Contact with another person with similar symptoms was reported by 14.7% of the
patients in this study, but most of the symptomatic contacts did not seek medical care so
an exact diagnosis was not obtained. The type of contact that occurred was also not
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identified so it is not known if the contact was a potential source of infection, if there was
a common exposure or if the other person was even infected with Campylobacter,
although it possible that contact with another infected individual may not have been the
actual source of infection as well. In the FoodNet case-control study, 7% of cases
reported a household member with diarrhea in the 4 weeks before illness compared to
11% of controls[198]. In that study, having a household member with similar symptoms
was identified among the controls as a protective factor since the control patient may
have been exposed previously and may have developed immunity but were not
symptomatic during the earlier infection.
Due to the possibility of fecal exposure, contact with dirty diapers has been
associated with transmission of campylobacteriosis, and therefore childcare or daycare
centers could be important sources of its spread[305]. In ET, 8.4% of cases reported the
risk factor “household member in daycare” (inclusive of the patient). The FoodNet casecontrol study of infants, reported that attending childcare was not significantly associated
with campylobacteriosis in the multivariable analysis[14]. In this study, having a
household member in daycare was associated with age; the 3 age groups with the highest
percentages were: under 5 (13.5%), 30-49 (12.9%) and 5-14 (8.5%). The 15-29 (3.3%),
65 and over (2.9%), and 50-64 (0%) age groups had lowest percentages. This
association may be due to differences in family structure, the 30-49 year olds may have
children of the age that could be in daycare, while the children under age 14 could have
siblings that are. Although it was not identified as a significant risk factor in previous
case-control studies, several outbreaks of campylobacteriosis have occurred at daycare
centers[225].
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The average annual prevalence of campylobacteriosis over the 4 year study period
in East Tennessee was 10.4 cases per 100,000 population. This is significantly lower
than that of the entire FoodNet region (12.7 cases/100,000 population) and significantly
higher than that of the state of Tennessee (7.4 cases/100,000 population). It is possible
that these prevalence estimates reflect the true prevalence of disease in ET, Tennessee
and around the US. There are also numerous factors that could influence disease
reporting and the reported prevalence, which may be responsible for a portion of the
observed differences in the prevalence of campylobacteriosis. Some parts of the state or
country may have different or better reporting practices by the laboratories involved
despite the active surveillance conducted by the health departments. This may result in a
higher percentage of the cases identified in the laboratories and a higher percentage
reported to the health department. Another possible factor is that doctors in some areas
may be more likely to request a stool sample/culture from their patients which could lead
to a higher percentage of cases identified in those regions. Worldwide a higher
percentage of children seek medical care for their symptoms than adults, but it is possible
that this difference may be more pronounced in some areas compared to others. Another
factor that could influence the decision to seek care (and disease reporting) is access to
medical care. In some states there is better state insurance and a difference in the
percentage of the population that has private insurance exists. The areas with a higher
percentage of the population insured may have a higher reported prevalence of
campylobacteriosis since more patients are seeking medical care and therefore more are
entered in the reporting database. In this study, the majority of patients were classified as
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white (>95%), so comparisons across race and ethnicity could not be made due to the
small sample size of the other races.
The patterns of age- and sex-specific prevalence estimates observed in this study
are similar to those reported in previous studies. Children under 5 years of age had the
highest prevalence of campylobacteriosis (41.6 cases per 100,000). This is significantly
higher (p=0.0051) than reported in 1999 of 7 FoodNet sites which found a prevalence of
30.9 cases per 100,000[239]. While the prevalence of disease among children under 5
was higher in ET than the rest of the US, it was lower than that reported in Ontario,
Canada (52.5 cases per 100,000)[292], the Eastern Townships of Quebec, Canada (169.2
per 100,000)[197] and Manitoba, Canada (males: 53.6 per 100,000, females:40.4 per
100,000)[244]. Although a bimodal age distribution has been reported in other studies in
the US[239] and worldwide[4, 19, 292], a second peak (prevalence above the average)
was not observed in the young adult population (ages 15-29) in the present study. Some
authors have hypothesized that the second peak may be due to a higher proportion of
young adults traveling to other countries where they may be exposed to Campylobacter.
The lack of the second peak in ET may be due to a relative lower proportion of travel
reported by young adults compared to other areas where the peak was observed.
The higher prevalence in young children in ET compared with other FoodNet
sites may be due to differences in the age at first exposure. On average, ET is more rural
than the other FoodNet sites and therefore children may be exposed to and infected with
Campylobacter at a younger age in ET since there may be greater chance of exposure in
the rural areas where animals, especially farm animals are more common. This is
compared to more urban areas where a larger percentage of the population may not be
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exposed until later in life. This hypothesis is supported by the findings of a study in
Manitoba, Canada which reported that the incidence of campylobacteriosis was much
higher among young children in the rural areas(males: 97.5 per 100,000, females: 72.8
per 100,000), compared to the urban ones(males: 13.2 per 100,000, females:10.5 per
100,000)[244]. In the urban areas of that study, the highest incidence was observed in the
20-24 year olds. Worldwide the highest prevalence estimates have been observed in
young children. Some of the high reported prevalence estimates may be due to the lower
inocula needed to infect an infant. Young children also often place foreign objects in
toys in their mouths; this behavior could also lead to more young children becoming
infected. Another reason for the high prevalence in young children may be due to a
greater proportion of young children seeking medical care. Parents are more concerned
when their 1-year-old is sick than when they (the parents) themselves are sick[233].
Grainger County had the highest age- and sex-standardized average annual
prevalence of campylobacteriosis at 22.9 cases per 100,000 population. This prevalence
is twice the average for the study region, and three times the average prevalence of the
state of Tennessee. Several other counties had standardized prevalence proportions that
were higher than the average prevalence of the study region. Jefferson County (21.8
cases/100,000 population) borders Grainger County to the South and Union County (14
cases/100,000 population) borders Grainger County to the West, these three counties
could be grouped to form a group of high risk counties. These three high risk/prevalence
counties are all rural areas (<25% urbanicity) which may explain the observed, above
average prevalence proportions reported in these 3 counties. A similar pattern was
observed in Manitoba, Canada where researchers reported that the prevalence of
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campylobacteriosis was higher in almost every age group in the rural areas compared to
the urban ones in the city of Winnipeg[244].
The standardized prevalence proportions were also above the average in Blount
(15.6 cases/100,000 population) and Loudon (13.1 cases/100,000 population) Counties.
Unlike Grainger, Jefferson, and Union counties, Blount and Loudon counties both fall
into the 2nd urbanicity group (44-66% urban) since 63.2 and 50% of the populations live
in an urban area, respectively. The reason for this finding is unknown. Geographically,
in between these two areas (Grainger, Jefferson and Union, and Blount and Loudon
counties) of above average prevalence is the most populous county, Knox County.
Although Knox County is 87% urban and some studies have identified an association
between urban dwellings and high prevalence of disease[239], the standardized
prevalence in Knox County was only slightly above average at 11.8 cases per 100,000
population. The age- and sex-standardized prevalence estimates shown in Figure 4.2 for
each CCD show how the areas of high prevalence extend across the county lines. The
map shows that the area of high prevalence in Grainger and Jefferson counties is
clustered toward the Western ends of the counties and this area of high prevalence
crosses into Eastern Knox County. While some of the areas of the map are white, this
does not indicate that campylobacteriosis is not occurring in these areas; just no cases
were reported to the health departments from those areas. The prevalence estimates also
show the areas of higher prevalence within each county that can be useful in health
planning.
It appears that the reported prevalence of campylobacteriosis is decreasing in East
Tennessee while it remains steady in the state of Tennessee and the rest of the US
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FoodNet. Future years will show whether the prevalence of campylobacteriosis in ET
will reach the average of the state or drop below it.
A marked seasonal pattern in the prevalence of campylobacteriosis was observed.
A peak occurred each summer, which is consistent with the findings of several other
published studies[4, 204, 231, 242, 243]. A study in Alberta and NewfoundlandLabrador, Canada found that there was a non-linear association between the ambient
temperature and the case counts of reported campylobacteriosis[306]. For every degree
increase in the mean weekly temperature, the number of cases of campylobacteriosis
reported increased by 6% in Alberta and 4.5% in Newfoundland-Labrador. Another
study that analyzed surveillance data from 15 countries in Europe, New Zealand,
Australia and Canada, found that all countries showed a distinct seasonality and that
countries with a milder winter were more likely to have a spring peak in the prevalence of
campylobacteriosis[307].
The increase in the reported prevalence of campylobacteriosis during the warmer
summer months may be due to an increase in risky behavior (hiking, camping, fishing or
swimming) during the summer months. Outdoor activities, especially recreational water
exposure, put the population at a greater risk for Campylobacter infections; since these
activities bring the population into closer proximity with possible sources of infection,
such as untreated water. Another reason for the summer increase in the prevalence may
be an increase in the number of outdoor barbecues which could lead to an increase in the
consumption of under cooked meat or greater opportunity for cross contamination of
foods.
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The highest peak in the prevalence of campylobacteriosis in East Tennessee
occurred in the summer of 2003, the same year as the highest annual prevalence for the
study. Identification of seasonal patterns among residents of ET can assist health
department personnel in directing their scarce education resources and timing prevention
efforts to have the greatest impact.

5.1

Strengths and Limitations
Under reporting of campylobacteriosis is a limitation of this study. There are

numerous steps (Figure 2.1) that must be taken in order for a case to be reported and be
entered into the surveillance database.

As such, not every case of campylobacteriosis

that occurred in ET is included in the database of this study. In addition, the proportion
of cases that go unreported may not be the same for all age, sex and socioeconomic
groups and geographic locations. So it is possible that certain population groups are over
or under represented in the prevalence estimates. The differences in population groups
that are reported may be due to differences in access to medical care and laboratory
facilities, physician practice and patient compliance of each group. It is possible that
doctors in rural areas may be less likely to request a stool sample due to the distance to
the nearest laboratory, adults may be less likely to comply with a doctor’s request for a
stool sample due to their schedule, or less likely to comply with the request if their
symptoms improve before sample collection, and some patients may be less likely to visit
a doctor if their symptoms are not as serious. A Canadian study of physician practices
found that doctors were more likely to request a stool sample if the patient reported
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bloody diarrhea, recent overseas travel, an immunocomprised status or a duration of
illness >7 days[308]. In that study physicians indicated that laboratory availability, the
time required to get a laboratory diagnosis and cost also influenced their decision to
request a stool sample. Regional differences in patient behavior and physician practice
that affect disease reporting can make comparing the prevalence of campylobacteriosis in
ET to other states and other countries difficult. These differences could include the more
rural nature of ET that might indicate fewer diagnostic laboratories that are located a
greater distance from the patients compared to other parts of the US. A big difference
between the US and other countries is the difference in health care systems; countries
with universal government funded health care may have higher rates of reporting since
more patients have health insurance and are therefore able to visit the doctor. However;
if surveillance system stable over time, reported prevalence can identify trends in true
prevalence.
Another limitation of this study is that the data collected on clinical symptoms,
and risk factors were self reported and voluntary. For other variables the data were not
collected in a standardized manner, such as information on the health status of the animal
the patient was exposed to or the treatment protocols of the private household wells; the
information was recorded for some patients, but not for all. In some cases the respondent
could not supply the information requested, therefore, unknowns and missing information
occurred frequently for some variables. The missing information could lead to biased
results if patients that did not provide the requested information were systematically
different from the rest of study patients.
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A strength of this study is that the data used were collected through active
surveillance; this means that every stool culture that was positive for campylobacteriosis
should have been reported to the health department. While the number reported is lower
than the actual total number of campylobacteriosis cases that are occurring in the region,
all cases identified during the study period were included in the study database, so the
prevalence calculated should reflect the trends that are occurring in the prevalence of
campylobacteriosis in ET. The data storage system and case report form changed during
the study period, but the law governing disease reporting did not. While the wording of
some of the risk factor variables changed, the basic information collected did not change
over the 4 years of the study. All errors that were created by the change in the database
structure in 2004 were corrected before analysis was conducted so this should not
influence the conclusions either. Since all cases were reported to the health department
in a similar fashion throughout study period, the data within ET can be compared across
years of the study.
Another strength of this study was a data quality evaluation that was performed
prior to analysis. Often the data obtained through surveillance systems is assumed to be
accurate. The data quality evaluation of the data used in this study showed that the
average error rate (6.5%) was within the range of error rates from other evaluations of
computerized records[267]. This evaluation shows that the data used in this study is
primarily accurate, can be trusted and can be used to analyze the trends of
campylobacteriosis in ET.
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5.2

Conclusions
In East Tennessee the reported prevalence of campylobacteriosis is declining. On

average, the prevalence is lower than that reported in all of the FoodNet sites within the
United States. However, the annual prevalence is, on average, 1.6 times higher than the
whole state of Tennessee. Several counties (Grainger, Jefferson, Union, Blount, and
Loudon) in the region have an average annual prevalence that is much higher than the
regional average and some are higher than the national average. Similar to other studies,
a large spike in the prevalence of disease occurred during the summer months.
The highest age-specific prevalence (41.57/100,000) was observed in young
children under 5. This is higher than the prevalence for the same age group in the rest of
the United States (24.01/100,000). The median age was lower in the more rural counties;
children comprise a larger percentage of the cases in these areas than the urban ones.
While the quality of the data used in this study was within the range of previously
published reports on data entry rates, some patterns were identified that affected data
quality in this study. Changes in the database storage system, in 2004, affected data
integrity. With the current database storage system, further errors such as these are not
likely to occur. It was also noted that several patients were assigned a race or ethnicity in
the computer dataset, when none was indicated on the paper case report form. In order to
ensure the accuracy and integrity of the dataset, more care needs to be taken when
transcribing information from the data collection form to the electronic database.
A larger percentage of campylobacteriosis patients were hospitalized in ET, but
the LOS was shorter for patients in this study than the rest of the US and other countries.
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Unlike what has been reported in other countries, the percentage of cases hospitalized, in
this study, varied with the season, the highest percentage occurred in the summer.
The clinical characteristics of patients in this study were largely similar to those
of other published reports. Almost all patients experienced diarrhea (97.5%) while only
37.8% reported blood in their stool, which is comparable to worldwide reports. Bloody
stool was found to be significantly associated with age; young children had much higher
odds of reporting this symptom than the rest of the population. Fever and cramps,
however, were reported less frequently in this study than other parts of the US.
The most commonly reported risk factor was recent animal exposure, with young
children 3 times more likely to report animal exposure than adults over 50. Other
hygiene related risk factors (handling raw meat, a household member in daycare) were
associated with age as well. Almost a third of the cases reported a well as the drinking
water source of the household; this was higher in the more rural counties and among
young children.
No factor or factors were identified that would explain why the prevalence of
campylobacteriosis is higher in East Tennessee than the rest of the state.

5.3

Recommendations and Future Research

5.3.1 Recommendations to the Health Departments
•

Focus education programs on areas of high risk, especially Grainger and Jefferson
Counties. These programs could include school presentations or pamphlets
focusing on hygiene (especially around animals). Pamphlets could also be
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developed for distribution to parents on how to make hand-washing fun for
children. These “games” could be distributed as posters to childcare centers and
nursery schools to encourage thorough hand-washing. This information could
also be included on a regional health department website with links to some of the
many internet resources already available.
•

In store education could be coordinated with area grocery stores to provide
displays emphasizing the need to keep raw meat (and its juice) separated from
other foods in the grocery cart, in the refrigerator and during preparation

•

Promote private well protection and treatment information.

•

Set a definition for the animal exposure risk factor and collect more information
on the type of exposure (occupational, live on a farm, school trip, household pet
or pet of a friend, or animal sleeps in bed), or average length of exposure to better
quantify the animal exposure and possible Campylobacter transmission.

•

Target altruistic and church groups with educational information for travelers to
rural areas or international destinations where acquiring campylobacteriosis may
be more common to ensure these groups are aware of the possible exposures for
Campylobacter spp. and other enteric pathogens. Information has been by the
CDC and this information could be assembled in a pamphlet or power
presentation and given to groups that routinely travel overseas such as churches.

•

Improve quality of surveillance data through more thorough collection and
accurate data entry.
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5.3.2 Future Research
In order to better understand the prevalence of campylobacteriosis in household
pets of East Tennessee, a study should be conducted to randomly sample animals in their
normal habitat for the presence of all thermophillic Campylobacters. The study would
investigate dogs that have frequent contact with other dogs to determine the prevalence of
Campylobacter spp. This could be studied by routinely sampling dogs at parks or other
areas where dogs frequently come in contact with each other. High prevalence of
campylobacteriosis amongst the dogs at each park may be used to justify rules governing
the pick up and sanitary disposal of dog feces in parks, and could be used to educate the
public about Campylobacter transmission.
Since there is a large percentage of the patients in this study that have a well as
the source of water for the household, a survey of wells in the region should be conducted
to test for contamination. This survey could also include repeat sampling after periods of
heavy rain to investigate if Campylobacter is washed into well water with rain water
runoff.
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Appendix A
Information Obtained by East Tennessee Regional and Knox County
Health Departments on Campylobacteriosis Case Report Forms
A.1 Information collected on campylobacteriosis case report form used
from 2003-2005
Demographics
Full name
Complete address
Phone number
Date of birth
Sex
Race (white, black, native-American, Asian/pacific islander, unknown)
Ethnicity (Hispanic, non-Hispanic, unknown)
Employer, School, Daycare or After-school center attended
Clinical Data
Date/Time of symptom onset
Symptoms (diarrhea, bloody stool, fever, headache, nausea, vomiting, cramps, muscle
aches, fatigue, other)
Duration of symptoms
Treatment
Physician visit (doctor’s office, urgent care, emergency room, none)
Physician name
Hospitalized (yes, no, unknown)
Hospital name, Admission date, Discharge date
Laboratory Data
Specimen source (stool, blood, urine, none, other)
Date of sample collection
Laboratory test conducted (culture, ova & parasite, serological, other)
Name of the reporting laboratory
Date of laboratory report
Exposures
Travel to another state or country in the two weeks prior to onset? (location, date)
Contact with any animals? (list)
Handle raw meat/poultry? (yes, no, unknown)
Household member in daycare?
Contact with person with similar symptoms?
Hike, camp, fish, or swim?
Drink from a spring, stream, or lake?
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Household water supply (city, well, spring, other)
List of household members (age, relationship, symptomatic, date of onset, also tested,
occupation)
Food History for 3 days prior to onset of symptoms
List of restaurants dined at 1 week prior to onset of symptoms
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A.2 Information collected on campylobacteriosis case report form, 2006
Demographic
Full Name
Date of Birth
Reported Age
Sex
Full Address
Phone Number
Ethnicity (Hispanic, not Hispanic)
Race (American Indian/Alaskan, Asian, Black/African American, Hawaiian/Pacific
islander, White, other)
Employer/School/Daycare
Occupation
Laboratory Report
Reporting facility
Ordering facility
Ordering provider
Laboratory report date
Date received by Health Department
Specimen source (blood, stool, cerebral-spinal fluid, urine, other, unknown)
Date sample collected
Clinical Information
Physician
Was the patient hospitalized for this illness? (yes, no, unknown)
Hospital, Admission date, Discharge date
Diagnosis date
Is the patient pregnant?
Did the patient die from this illness?
Epidemiologic Information
Is this patient associated with a daycare facility?
Is this patient a food handler?
Is this case part of an outbreak?
Where was the disease acquired? (indigenous, out of jurisdiction, out of state, out of
country, unknown)
Transmission mode (foodborne, waterborne, zoonotic, indeterminate, other)
Symptom History
Date/Time of illness onset
First symptoms
Symptoms (abdominal cramps, backache, bloody diarrhea, chills, constipation, diarrhea,
fatigue, fever, headache, muscle aches, nausea, vomiting)
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Date/Time of recovery
Duration
Travel History
Did patient travel prior to onset of illness?
Type (domestic, international)
Destination (date of arrival, date of departure)
Mode of travel (airplane, bus, car, cruise, ship, train)
Related Cases
Does the patient know of any similarly ill persons?
Are there any other cases related to this one?
Possible Source(s) of Infection During Exposure Period
Consumed any poultry? Undercooked?
Handled raw poultry
Consumed food at a group meal
Consumed food from restaurants
Contact with diapered children
Contact with any other persons having diarrhea
Occupational exposure to human or animal excreta
Drinking Water Exposure
Household water source (do not use tap water, municipal or city, private well, other,
unknown)
If private well, how was the well treated?
What is the source of tap water at school/work?
Did the patient drink untreated water in the 7 days prior to onset of illness?
Recreational Water Exposure
Was there recreational water exposure in the 7 days prior to illness?
(hot spring, hot tub-whirlpool-jacuzzi-spa, interactive fountain, lake-pond-riverstream, ocean, recreational water park, swimming pool, other, unknown)
Animal Contact
Did the patient visit or live on a farm?
Did the patient visit a live animal exhibit?
Dif the patient come in contact with any animals?
Type of animal (cat, cattle, chicken, dog, goats, lizard, other, other amphibian, other
mammal, other reptile,
rodent, sheep, turkey, turtle, unknown)
Location of animal contact
Did the patient acquire a pet prior to onset of illness?
Patient Prophylaxis/Treatment
Was the patient treated with any antibiotics for this illness?
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A.3 Variables included on the campylobacteriosis case report form that
were added to the electronic dataset
Laboratory test ordered (stool culture, ova and parasite, serological)
Date of onset
Clinical symptoms (yes, no; fever-specific temperature)
Duration of symptoms
Treatment
Location of physician visit
Animal exposure
Other risk factor exposures (raw meat, other cases, daycare, outdoor activity, drinking
untreated water)
Household water source (well, city, spring, other)
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A.4 Variables present in the electronic campylobacteriosis datasets
obtained from the East Tennessee Regional and Knox County Health
Department
Years in the dataset
Variable*
City
All
Address
2003-2004
State
All
County
All
Zip code
All
Birth date
All
Age
All
Race
All
Ethnicity
All
Gender
All
Serotype
2004-2006†
Specimen source
All
Date of specimen collection/diagnosis date
All
Date reported
All
Outcome
All
Patient Status (hospital, outpatient, unknown)
All
Patient hospitalized?
2003, 2005-2006
Hospital name
2003-2004
Admission and discharge dates
All
Travel
2004-2006
Destination and travel dates
2005-2006
Reporting laboratory name
2004-2006
*
Some variables, that had no pertinent information to this study, were excluded from the
list
†
Some information on serotype was collected in 2003 in the “other” variable field, but
data were incomplete
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A.5 New variables created from information provided on the
campylobacteriosis case report form
Antibiotic prescribed (yes, no, unknown)
Class of antibiotic
Intravenous fluids given (yes, no, unknown)
Anti diarrheal or anti nausea medication given (yes, no, unknown)
Number of treatments
Age group
Severity (mild, moderate, severe)
Time waited before seeking medical care
Days spent in hospital (Length of stay)
Season
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Appendix B
Counties Groupings Determined by Urbanicity and Prevalence of
Campylobacteriosis Created for Analysis
B.1 Groupings of the study region based on the urbanicity of the county
Grouping
Group 1 (66% or more)
Knox County
Hamblen County
Group 2 (44 – 66%)
Blount County
Anderson County
Roane County
Loudon County
Group 3 (22 – 44%)
Campbell County
Sevier County
Cocke County
Claiborne County
Jefferson County
Monroe County
Group 4 (0 – 22%)
Morgan County
Scott
Grainger
Union

Percentage of population living in an urban area
87%
75%
63%
58%
51%
50%
43%
35%
33%
30%
25%
23%
18%
15%
0%
0%
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B.2 Groupings of the study region based on the prevalence of
campylobacteriosis in the county
Grouping

Group 1 (0 – 6 cases/100,000 population)
Hamblen County
Roane County
Scott County
Morgan County
Group 2 (6 – 12 cases/100,000 population)
Campbell County
Sevier County
Cocke County
Claiborne County
Anderson County
Monroe County
Knox County
Group 3 (12 – 18 cases/100,000 population)
Loudon County
Union County
Blount County
Group 4 (18 – 24 cases/100,000 population)
Jefferson County
Grainger County

Age- and Sex-Standardized
Mean Annual Prevalence
(cases/100,000 population)
3.8
4.4
5.1
5.7
7.1
7.6
8.7
8.8
9.3
9.3
11.8
13.1
14.0
15.6
21.8
22.9
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B.3 Map of the counties in the study region grouped based on the age- and sex-standardized prevalence of
campylobacteriosis
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